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This study addresses synthetic approaches to access a glycine-derived 
thiomorpholinone  template and the application of this template for the production of 
peptides via C-terminus extension. 
 
The first chapter surveys strategies in peptide synthesis, including stepwise elongation 
and convergent approaches.  Several important amino and carboxy protecting groups 
are described. The development of methodologies in peptide synthesis, beginning with 
solid phase peptide synthesis (SPPS) towards chemical ligation, native chemical 
ligation (NCL) and other ligation techniques such as Staudinger ligation and click 
chemistry, are considered. The racemization problem in peptide synthesis via direct 
enolization and oxazolone formation are highlighted. Several widely used coupling 
reagents such as acyl chloride, carbodiimide and phosphonium reagents are discussed. 
The development of a morpholinone to thiomorpholinone-based peptide synthesis 
strategy is summarized.  
 
Chapter 2 focuses on an alternative synthetic route to obtain glycine-derived 
thiomorpholinone templates. A seven step synthetic route was successfully developed to 
access C-3 unsubstituted thiomorpholinones for the first time. The synthesis starts with 
the nucleophilic ring opening of Boc-protected morpholinone to give an ester. The 
sulfur introduction was achieved via Mitsunobu reaction, followed by hydrolysis, ring 
closure with DCC and deprotection to give the desired glycine-derived 
thiomorpholinone template. Attempts to improve the initially developed method 




pot strategy. An attempt at incorporation of a 5-(4-methoxyphenyl) substituent into the 
thiomorpholinone system was able to give an ester by adapting an improved six step 
procedure. 
 
Chapter 3 concentrates on several other routes investigated with the aim to access the 
glycine-derived thiomorpholinone template. In a reductive amination approach,  benzyl 
N-Fmoc 2-(4-methoxyphenyl)thioglycine  was generated based on a six step procedure 
requiring two more steps including benzyl removal before ring closing to obtain the 
more synthetically attractive 5-(4-methoxyphenyl) C-3 unsubstituted thiomorpholinone 
template. The use of thioacetate as an alternative starting material in this approach 
successfully led to the thioacid in three steps. A thionation approach was also 
considered for the conversion of the morpholinone precursor to the thiomorpholinone. 
Several thionating agents were studied for this purpose, including Lawesson’s reagent, 
a P4S10–HMDO combination and the P4S10-pyridine complex using Fmoc-protected 
morpholinone as a starting material. 
 
Chapter 4 describes an application of the C-3 unsubstituted thiomorpholinone template 
in peptide synthesis. This is exemplified by the preparation of a tripeptide derivative 
ala-gly-ala. The N-terminus peptide extension on the template was carried out using an 
acid chloride to give a dipeptide adduct ala-gly. The nucleophilic ring opening of N-
acylated thiomorpholinone was achieved using a carboxyl protected amino acid under 
mild conditions to give the ala-gly-ala tripeptide precursor. This study demonstrates that 
a glycine-derived thiomorpholinone can be used as a template to carry out C-terminus 





Chapter 5 summarises the main findings in this study including the development and 
improvement of the synthetic method to access the desired glycine-derived 
thiomorpholinone template and also the use of this template towards peptide generation. 
 
Chapter 6 outlines the experimental procedures and spectroscopic data of the 
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KEH Potassium 2-ethyl hexanoate 
Me Methyl  
MOM Methoxymethyl  





ppm parts per million 
PyBop (benzotriazolyloxy)-tris-(pyrrolidino)phosphonium 
hexafluorophosphate 
PyBrop Bromotripyrrolidinophosphonium hexafluorophosphate 
Rf Retention factor 
RNase A Ribonuclease A 
SN2 Nucleophilic substitution, second order 
SPPS Solid phase peptide synthesis 
STAB Sodium triacetoxyborohydride  
TMS Trimethylsilyl 
t-Bu tert-butyl 
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1.1 Introduction to the strategy for chemical synthesis of peptides 
Proteins play an important role in biological processes including enzymatic reactions, 
transport/storage (haemoglobin), immune protection (antibodies) and mechanical 
support (collagen). With significant roles in various biochemical reactions by 
demonstrating high specificity towards their molecular target,
1
 proteins and peptides 
have attracted a lot of attention from synthetic chemists and pharmacists in exploring 
their potential as drug candidates. Based on information from the THPdb database in 
2017, since the 1980s, 239 therapeutic peptides and proteins have been approved by the 
United States Food and Drug Administration (FDA) for clinical use.
1
 More than 60 
peptide-based drugs are currently available on the market and several other peptides are 
under clinical development.
1,2
 There are various applications of peptide drugs in the 
medical and pharmaceutical field, delivering treatments for cancer, diabetes, obesity, 
osteoporosis, allergies, immunological disorders and cardiovascular disease.
1,2
  
As a result, the chemical synthesis of proteins has become an important area of 
research, resulting in the rapid development of new techniques and methodologies over 
recent years, with the aim of creating novel peptides with desirable properties based on 
a range of methods such as de novo design, template-based modelling or by altering 
natural frameworks. The chemical synthesis of proteins allows the facile incorporation 
of unnatural functionality into these structures. Many peptide-based products that 
demonstrate interesting biological activities contain amino acid building blocks that 
may not be easily introduced by traditional peptide coupling reagents and reactions.
3
 




methodologies continues to be required so that difficult peptide coupling reactions are 
rendered more efficient. Above all, in any process, the peptide bond should be formed 
rapidly and quantitatively under mild conditions, avoiding side reactions without 
interfering with the integrity of adjacent stereogenic centres and producing only easily 
removed by-products.  
The advances in peptide synthetic methodology have brought about the growth and 
expansion of protein synthesis. Many peptides have been successfully synthesized and 
reported. For example, the octapeptide hormone oxytocin was successfully synthesized 
through solution phase synthesis  and an enzyme ribonuclease (RNase A) was 
synthesized through solid phase methodology.
4
 Nowadays, peptide synthesis through 
solid phase methodology is the most common strategy and the efficiency of this method 
continues to improve. Unfortunately, solid phase peptide synthesis is generally limited 
to peptides that contain fewer than 40 residues; the synthesis of peptides and proteins 
with greater length being far more difficult to accomplish. Most proteins are simply too 
long to synthesize by the simple repetitive stepwise coupling of amino acid monomers.
4
 
It has been reported that the convergent coupling of protected or partially protected 
peptides in solution and on solid phase is a better approach to access proteins with more 
than 40 residues.
4
 This strategy is claimed to minimize side reactions, increase the 
efficiency of amino acid coupling and more importantly can reduce the risk of 
epimerization.  
1.2 Strategy in peptide synthesis 
In principle, peptides can be synthesized based on either a stepwise elongation strategy 
or a convergent fragment condensation strategy. For example, a tetrapeptide could be 




[1+(2+3)]+4 and 1+[(2+3)+4] in which one residue is added for coupling at a time 
(Figure 1.1).
5
 Alternatively, in a convergent approach, dipeptide fragments could be 
prepared before condensing them together into a tetrapeptide (Figure 1.1).
5
 From a 
simple arithmetic point of view, the convergent method will give a better yield of 
approximately 64 % if an 80 % yield is obtained at each stage, compared to a stepwise 
elongation strategy that will only produce around 52 % overall yield. Peptides produced 
through a convergent strategy are generally easier to purify than those prepared by the 
stepwise method as stepwise synthesis can lead to deletion products where an amino 
acid residue has only incompletely coupled. Furthermore, the synthesis of peptide 
fragments can be carried out simultaneously in parallel, in contrast with the stepwise 
method that must be performed sequentially. Thus, a set of precursor peptides with 
variable sequences can be synthesized before assembling them into a larger peptide. 
However, the selection of fragment position is crucial in a fragment condensation 
approach, introducing constraints because the coupling reaction may only work 
efficiently in terms of yield or stereoisomeric purity at certain positions. 
 
 
(a) Stepwise elongation (1+[2+(3+4)])             (b) Convergent, fragment condensation 
 




1.3 Protection in peptide synthesis 
1.3.1 -Amino protection 
Amino group protection can be achieved by suppressing its nucleophilic reactivity with 
an appropriate substituent that diminishes electron density on the nitrogen. The 
protecting group should be able to remain in position as long as it is required and then 
readily removed without affecting the integrity of the structure. 
1.3.1.1 Benzyloxycarbonyl (Z) protection 
The benzyloxycarbonyl (Z) group 1 was the first amino protecting group developed in 
1932 by Bergmann and Zervas.
5,6
 The Z group was initially introduced onto the amino 
group as the chloroformate reagent, but this protocol leads to unwanted side reactions 
such as dipeptide formation and so the use of less reactive acylating agents is now 
preferred. This protecting group is stable under mildly basic and acidic condition and to 
nucleophilic reagents such as amines, hydrazine and dilute alkali. The deprotection 
reaction can be carried out with HBr/AcOH by a SN2 mechanism (Scheme 1.1).
5
 Most 
protected peptides are readily soluble in acetic acid and the deprotected products can be 






Scheme 1.1 Mechanism of removal of the Z group with HBr/AcOH 
 
1.3.1.2 tert-Butyloxycarbonyl (Boc) protection 
In 1957, the tert-butyloxycarbonyl (Boc) 2 protecting group was introduced by McKay 
and Albertson.
7
 The precursor anhydride is considered safer to use than the 
corresponding chloroformate and is stable on storage for long periods if kept in a 
refrigerator. The Boc group removal can be reliably carried out under mild conditions 
by dissolving the substrate either in neat TFA or TFA in dichloromethane at room 
temperature for half an hour (Scheme 1.2).
5
 This protecting group is stable towards 










1.3.1.3 9-Fluorenylmethoxycarbonyl (Fmoc) protection 
The 9-Fluorenylmethoxycarbonyl (Fmoc) 3 was developed as an amino protecting 
group in 1970 by Carpino and Han.
8
 The Fmoc group is usually introduced onto the 
amino group using the chloroformate precursor but this has a tendency to cause side 
reactions, such as dipeptide and tripeptide production, similarly to benzyl 
chloroformate. However, the development of less reactive derivatives such as the 
succinimido ester derivative is now preferred as it generally gives better yields.  
 
 
The Fmoc group is very stable towards acids, while deprotection is effectively carried 
out under basic conditions using piperidine (20 % in DMF), usually taking only a few 









1.3.2 Carboxylic protection 
Carboxylic protection is required when the carboxylic component of the other amino 
acid or peptide is activated in the presence of the amino component and all such 
protection is based on esterification. Regeneration of the parent carboxylic acid from 
the ester is accomplished by acyl-oxygen or alkyl-oxygen cleavage depending on the 
ester used. Carboxylic protection as a methyl ester can be performed with hot 
methanolic hydrogen chloride to afford the methyl ester hydrochloride, generally as a 
crystalline product.
5
 Treatment with thionyl chloride in methanol is a convenient means 
of generating the reaction medium. Methyl group protection provides good stability, not 
only during the formation of the peptide bond, but also during the N-deprotection 
reaction as methyl esters demonstrate high stability towards HBr/AcOH, TFA, catalytic 
hydrogenolysis, thiols and amines.
5
 However, problems such as racemization may be 
encountered during methyl group removal as it has to be carried out under relatively 
harsh condition. 
Protection as a t-butyl ester can be performed directly from the amino acid by acid 
catalysed treatment with a solution of isobutene as shown in Scheme 1.4.
5
 The amino 
acid t-butyl ester is stable towards nucleophilic and basic attack, while treatment with 
TFA removes the t-butyl ester. 
 
 
Scheme 1.4 (i) DCM sat. with Me2C=CH2, H2SO4 (cat.), 20 
o






Phenyl esters are readily prepared and the resultant ester is commonly obtained as a 
crystalline material. These esters are stable towards acids and catalytic hydrogenation 
and can be removed with alkali or alkaline peroxide as they are susceptible to 





Scheme 1.5 pH 20.5, 20 
o
C, aq. DMF 
1.4 Solid phase peptide synthesis 
In 1963, Merrifield established a novel approach to synthesize peptides based on solid 
phase peptide synthesis (SPPS).
9
 In this approach, the N-protected amino acid is bound 
onto a resin followed by removal of the N-protecting group. The unprotected amino 
acid is then coupled with the second N-protected amino acid and the process is repeated 
until the desired sequence of amino acids is obtained, with the final steps involving side 
chain deprotection and cleavage of the desired peptide from the polymer support. The 
principle of amide bond formation on solid support is illustrated in Scheme 1.6.
10
 The 
repeated coupling and deprotection procedures and the nature of the growing peptide 
chain entail an appropriate selection of resin and protecting groups to avoid premature 
cleavage or alteration of the growing peptide. This methodology is now carried out on 







Scheme 1.6 Solid phase peptide synthesis 
 
1.5 Chemical ligation  
The absolute limitation of protein length to about 50 amino acids in advanced SPPS 
methodologies has led to the development of a new protocol in protein synthesis called 
“chemical ligation”.
11
 This method allows the coupling of two unprotected peptide 
fragments chemoselectively in aqueous solution to form a much longer peptide chain.
11
  
A chaotropic agent  such as 6 M guanidine-HCl is used to increase the solubility of the 
reacting segments and thereby accelerate the reaction.
12
 The principle of this chemical 
ligation technique is exemplified in the synthesis of an HIV-protease enzyme (Scheme 
1.7).
12
 In this approach, thiocarboxylate and bromoacetyl peptides containing 
approximately 50 residues each were reacted through a thioester-forming ligation to 





Scheme 1.7 Chemical ligation in peptide synthesis 
 
1.6 Native chemical ligation and other ligation techniques 
In 1994, Dawson et al. developed a native chemical ligation (NCL) technique that could 
assemble two unprotected peptide segments chemoselectively at neutral pH in aqueous 
solution to form a large polypeptide in which the newly formed linkage is an amide.
13
 
In this method, an N-terminal cysteine peptide and peptide--thioester are reacted, 
initially to give the thioester-linked intermediate that subsequently undergoes 
intramolecular nucleophilic rearrangement, resulting in the formation of the amide bond 








Scheme 1.8 Native chemical ligation in peptide synthesis 
This ligation technique has been widely applied in peptide synthesis. However, it is 
limited by its reliance on the presence of a cysteine residue at the N-terminus of one of 




In 2000, Staudinger ligation was introduced by Raines and Bertozzi.
15
 This method is 
based on the reaction between an azide and a phosphine to produce an 
iminophosphorane that then forms an amidophosphonium salt via an acyl shift reaction. 









Scheme 1.9 Staudinger ligation in peptide synthesis 
 
The concept of click chemistry was developed by Sharpless and co-workers in 2001 as 
another ligation tool, involving the copper (I)-catalysed addition of acetylenes to azides 
to form 1,2,3-triazoles.
17
 Triazole ligation allowed the construction of cyclic 
tetrapeptides in good yield and it was reported that formation of the triazole ring could 







Scheme 1.10 Synthesis of tetrapeptides using a copper(I)-catalysed azide-alkyne 
cycloaddition (click reaction) 
In 2003, the generation of an O-acyl ester linkage within the peptide backbone instead 
of the N-acyl amide linkage was reported to increase the solubility of a readily 
aggregated long sequence peptide by changing the secondary structure of the native 
peptide. The target peptide was then generated through O-N intramolecular acyl 








Scheme 1.11 O-Acyl isopeptide method in peptide synthesis 
 
1.7 The racemization problem in peptide synthesis 
 
Racemization is one of the primary concerns in peptide chemistry.  The loss of chiral 
integrity at one or more stereogenic centres will form a mixture of epimers that will 
lead to difficult purification problems. Due to its highly repetitive nature, efficient 
coupling is vital in peptide synthesis and so it is imperative to optimize the appropriate 
conditions at each coupling step to avoid epimerization and minimize side reactions in 
order to facilitate purification. Loss of chiral integrity can occur by two different 
mechanisms, direct enolization and the oxazolone formation. 
1.7.1 Direct enolization 
 
Deprotonation of the -carbon of an -amino acid will generate the carbanion 
intermediate that could reprotonate to lead to either the S- or R- configuration of the 
amino acid (Scheme 1.12).
5




leaving groups and the use of unhindered strong bases in dipolar aprotic solvents such 
as DMSO and DMF.
5
 Generally however, this mechanism only contributes slightly, if 
at all, to racemization during peptide synthesis.  
 
 
Scheme 1.12 Racemization in a peptide based on direct enolization 
  
1.7.2 Epimerization by oxazolone mechanism 
 
Oxazolone formation is encountered in peptide synthesis when a C-terminus activated 
acylamino acid cyclizes under mildly basic conditions (Scheme 1.13).
5
 The oxazolone 
acts as it were a C-terminus activating group and can therefore react with the amino 
group of another amino acid to produce a peptide bond. However, racemization of the 
oxazolone through its aromatic enol tautomer can occur to varying degrees alongside 
peptide bond formation. As a result, the peptide produced is, to a greater or lesser 
degree, epimerized at what had been the activated C-terminus. This reaction occurs 
rapidly if the amino nitrogen is acylated with a simple acyl group such as acetyl or 
benzoyl group, but also occurs if the acyl substituent is a peptide chain and can even 
result in complete epimerization with the use of good leaving groups that facilitate the 
cyclization to the oxazolone. Interestingly, if the acyl subsituent is replaced with an 




does not occur during the activation and coupling stages when using Z, Boc and Fmoc 





 Scheme 1.13 Racemization in a peptide chain based on oxazolone mechanism 
 
1.8 Carboxyl activation strategies 
1.8.1 Acyl chlorides 
The most simple and convenient approach to peptide synthesis is the activation of N-
protected amino acid by conversion to an acyl chloride followed by treatment with the 
C-teminus protected amino ester, either under Schotten-Baumann conditions or in an 
organic solvent. Thionyl chloride and phosphorus pentachloride are commonly used in 
acyl chloride formation but simple acyl amino acid chlorides tend to cyclize to 
oxazolones giving racemic material.
5
 This limitation to acyl chloride application in 
peptide chemistry was overcome through the development by Carpino of Fmoc acid 








Scheme 1.14 SOCl2, CH2Cl2, reflux, 15 minutes 
 
Various peptides have been successfully synthesized in good yields by employing Fmoc 
acid chloride methodology in the presence of zinc dust (Scheme 1.15).
21
 The amino 
acid ester hydrochloride is neutralized in situ using zinc dust instead of base prior to 
coupling, resulting in a peptide free from epimerization and with minimum side 
reactions. Coupling is usually fast and is normally complete within 15 minutes.  
 
 
Scheme 1.15  Zn, THF, room temperature, 15 minutes 
1.8.2 Carbodiimide coupling 
Dicyclohexyl carbodiimide (DCC) 4 was introduced by Sheehan and Hess in 1955
22
 as 
a carboxy- group activating agent. The discovery of this reagent led to a simple peptide 
coupling method involving addition of the N-protected amino acid to a solution of DCC 
in an organic solvent to give the O-acylisourea 5, a potent acylating agent (Scheme 
1.16).
5
 The O-acylisourea subsequently forms the peptide bond, either through direct 
aminolysis, or via the symmetrical anhydride with formation of dicyclohexylurea 6 
(Scheme 1.17).
5
 The separation of this by-product is generally not an issue as it has a 











However, an intramolecular acyl transfer of the O-acylisourea may occur to a 
significant extent to form unreactive N-acylurea 7 and this reduces the yield and leads 
to purification problems (Scheme 1.18).
5,10
 The use of 1-hydroxybenzotriazole (HOBt) 
as an additive as -nucleophiles to react preferentially with the O-acylisourea to 









1.8.3 Phosphonium reagents 
The phosphonium salt, (benzotriazolyloxy)-tris-(dimethylamino)phosphonium 
hexafluorophosphate) (BOP, 8) reagent was developed by Castro in 1975
23,24
 as a stable 
coupling reagent and started gaining popularity over DCC as it greatly lowered the risk 
of racemization, due to the rapid rate of coupling of this system, giving excellent yields 
and producing easily removed co-products (Scheme 1.19).
5,25
 The N-protected amino 
acid is deprotonated to generate the carboxylate anion and this subsequently attacks the 
positively charged phosphonium salt resulting in a nucleophilic BtO
–
 leaving group that 
reacts with the carboxyl group of the first intermediate in the presence of a tertiary 
amine such as triethylamine or diisopropylethylamine (DIPEA). The C-protected amino 






However, use of the BOP reagent generates the known carcinogen 
hexamethylphosphoramide (HMPA), thus limiting its application in peptide 
chemistry.
25
 As an alternative, the (benzotriazolyloxy)-tris-(pyrrolidino)phosphonium 
hexafluorophosphate) (PyBop, 9) reagent was developed and is reported to demonstrate 
all the advantages of the BOP reagent and, more importantly, to produce a less harmful 
by-product.
25
   
Two other phosphonium salts that are claimed to be even more efficient as coupling 
reagents are (7-aza-benzotriazolyloxy)-tris-(dimethylamino)phosphonium 
hexafluorophosphate (AOP, 10) and the slightly more reactive (7-aza-
benzotriazolyloxy)-tris-(pyrrolidino)phosphonium hexafluorophosphate (PyAOP, 11), 
neither of which generates HMPA.
25
 The pyrrolidino- derivative PyAOP was 
successfully used in a cyclization to produce the anticancer agent, didemnin 12 in an 










1.9 Development of a morpholinone-based peptide synthesis strategy  
1.9.1 The morpholinone template 
Due to the epimerization problems associated with C-terminus-activated, N-acylated 
amino acids, linear peptide synthesis is limited to C- to N-terminus direction in a linear 
extension protocol. The Harwood group has discovered the possibility for peptide 
coupling in a manner similar to that Nature carries it out, namely in the N- to C-
terminus direction, based on the morpholinone template. The (3S,5R)-3-methyl-5-
phenylmorpholinone template was constructed based on the method developed by 
Harwood and Vines (1996) (Scheme 1.20).
26
 This template was synthesized by reacting 
(R)-2-phenylglycinol with ethyl pyruvate for 24 hours in 2,2,2-trifluoroethanol to 
produce mainly dehydromorpholinone 13. The crude material was then purified by 




Hydrogenation of 13 under an atmosphere of hydrogen in dichloromethane using PtO2 
catalyst for 5 hours furnished the desired template 15. 
 
     
Scheme 1.20 (i) Ethyl pyruvate, 4 Å molecular sieves, TFE, ∆, 24 hours (ii) H2, 1 
atmosphere, PtO2, CH2Cl2, 5 hours 
 (3S,5R)-Morpholinones such as 15 can act as C-terminus activated amino acids, but an 
N-acyl substituent on the nitrogen is not able to reach the lactone carbonyl and therefore 
cannot form an oxazolone. This was demonstrated by heating N-acetyl morpholinone 16 
in DMSO-d6 at 120 
o
C for 3 weeks with no evidence of formation of the epimer at C-3 
(Scheme 1.21).
27 
A mixture of conformers was observed at temperature in a range of 20 
– 80 
o
C, due to slow interconversion between the two conformations of the amide as a 
result of restricted rotation around the amide bond, perhaps further induced by the steric 
interactions of the amide substituent with the substituent at C-3.
28
 However, when the 
temperature was increased to 120 
o
C, the free rotation around the amide bond showed 
the presence of only a single diastereoisomer indicating that the morpholinone based 
model for C-terminus based peptide synthesis should  indeed be free from 
epimerization. 
 
Scheme 1.21 (i) DMSO-d6, 120 
o




Furthermore, the N-terminus of the morpholinone template was successfully extended 
using classical solution phase methodology to form tetrapeptide derivative 17. In the 
first step of the chain extension, DBU in THF was used to remove the Fmoc protecting 
group from the morpholinone and then coupling with Fmoc-L-alanine was carried out 
using bromotripyrrolidinophosphonium hexafluorophosphate and N,N-
diisopropylethylamine (Scheme 1.22).
27
 Moreover, it was discovered that the N-
terminus extension of the morpholinone template was not limited to morpholinones 
with less bulky groups at C-3 and it was demonstrated that N-extended products were 
successfully furnished with bulky C–3 side chains such as propyl, benzyl or even tert-
butyl (Scheme 1.23).
27
 These findings indicated that N-terminus extension of the 




           
Scheme 1.22 (i) 10 mol % DBU, THF, 5 hours; DIPEA, PyBrop, Fmoc-L-alanine, 
THF, 18 hours; (ii) 50 mol % DBU, THF, 5 hours; DIPEA, PyBrop, Fmoc-L-alanine, 






Scheme 1.23 (i) N-Fmoc-L-alanine acid chloride, Na2CO3, CH2Cl2,1 - 48 hours 
 
It was known that the N-acylated morpholinone ring can react with nucleophilic 
species, leading to opening of the lactone ring (Scheme 1.24).
27
 Furthermore, it was 
suggested that the degree of substitution on the free amine might not have a significant 
steric effect on this opening
27
 and that the N-acylated morpholinone could thus play the 
role of a C-terminus activated dipeptide that would prevent the formation of oxazolone 
and therefore epimerization of the activated amino acid. However, by increasing the 
steric hindrance at C-3 with an isopropyl or benzyl morpholinone template, it was found 
that the aminolysis could not occur under the same conditions. 
 
 
Scheme 1.24 (i) t-butyl-L-valinate, Al(CH3)3, CH2Cl2, 24  hours 
 
Nevertheless, two simple tripeptides, L-ala-L-ala-L-ala 26 and L-ala-D-ala-L-ala 27 were 
successfully synthesized by adopting this approach. The synthetic pathways to these 








Scheme 1.25 (i) N-Fmoc-L-alanine acid chloride, Na2CO3, CH2Cl2, 1 hour; (ii) t-butyl-





                            
Scheme 1.26 (i) N-Fmoc-L-alanine acid chloride, Na2CO3, CH2Cl2, 1 hour; (ii) t-butyl-








1.9.2 The thiomorpholinone template 
Thiolactones are known to be more prone to nucleophilic attack than the lactone ring in 
the morpholinone template. Therefore, a synthetic route to novel thiomorpholinone 
analogues was developed in the Harwood group to investigate the reactivity of this 
system towards amide bond formation by thiolactone ring opening with the aim of 
finding milder and more efficient conditions for C-terminus extension. The original 
synthetic route for preparing the novel chiral thiomorpholinones is described in Scheme 
1.27.
30,31
 The Boc-protected L-amino acid was reacted with ethyl chloroformate at 0 
o
C 
for 30 minutes to activate the C-terminus. The resulting solution was then treated with 
sodium hydrosulfide hydrate to form the thioacid to which potassium 2-ethyl hexanoate 
was added. The potassium salt was subsequently reacted with 2-bromoacetophenone to 
form the thioester 28. The Boc-protecting group was then removed by adding 20 % 
(v/v) trifluoroacetic acid in dichloromethane followed by cyclization on treating the 
deprotected amine with anhydrous potassium carbonate or cesium carbonate to generate 
the corresponding isomeric dehydrothiomorpholinones 29 and 30. These were then 
diastereoselectively reduced with sodium cyanoborohydride in THF to furnish the 






   
Scheme 1.27 (i) Et3N, DMF, 0 
o
C, 30 minutes, (ii) ClCO2Et, 0 
o
C, 30 minutes, (iii) 
NaHS, 0 
o
C, 30 minutes, (iv) 1 M HCl, 0 
o
C (v) KEH, Et2O, 30 minutes (vi) 2-bromo-
acetophenone, DMF, 18 hours (vii) TFA, CH2Cl2, room temperature, 2 hours (viii) 
Cs2CO3 or K2CO3, CH2Cl2, room temperature, 24 hours (ix) (i) NaBH3CN, AcOH, 
THF, room temperature, 48 hours 
This study revealed that the thiolactone was readily attacked by nucleophilic solvents 
such as methanol, a process that did not occur in the morpholinone system (Scheme 
1.28)
30
 and the greater tendency of this template towards nucleophilic attack lent 
support to the proposal that the thiomorpholinone template could facilitate amide bond 






Scheme 1.28 (i) NaBH3CN, AcOH, MeOH, 24 hours 
 
1.10 Aims of this project 
 Several derivatives of 3,5-disubstituted thiomorpholinones have been successfully 
constructed in the Harwood group incorporating benzyl, isopropyl, butyl and methyl 
groups at C-3.
30
 However, it was found that the parent thiomorpholinone, with C-3 
unsubstituted, could not be accessed through that procedure.  Attempts at developing 
alternative synthetic routes to obtain this C-3 unsubstituted thiomorpholinone with a  5-
(4-methoxyphenyl) auxillary had been carried out by previous researchers in the 
Harwood group and it was reported to be more challenging to synthesize than other 
thiomorpholinone derivatives. Therefore, it was proposed that attempts to synthesize C-
3 unsubstituted thiomorpholinones 32 would be continued by considering other 
pathways and the reactivity of these templates, both as the free amine and as the N–
acylated form, would be studied with regard to ring opening amide bond formation 
(Scheme 1.29). In particular the stereochemical integrity of position 3 would be 
investigated in the case of the N–acyl derivatives. 
Thus, the development of thiomorpholinones as novel reagents for amide bond 
formation would be explored, to assess their capability to be used as templates for 
peptide coupling reagents. Using this model, the peptide chain could be extended, not 




acting as the activated C-terminus without epimerization by analogy with the N-
acylated morpholinones, where intramolecular interaction to form an oxazolone is 
prevented.  It was therefore expected that the 5-phenylthiomorpholinone motif could 
generate an amide bond by C-terminus extension without C-terminus epimerization and 
then be N-debenzylated under conditions more amenable to peptide synthesis. 
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Synthesis of glycine derived thiomorpholinones  
  
Several 3(S)-R-5(R)-phenylthiomorpholinone derivatives possessing bulky substituents 
such as benzyl, isopropyl, butyl and the less bulky methyl group have been successfully 
synthesized in previous work within the Harwood group in good overall yields that 
range from 62 – 86 %.
1
 However, the synthesis of the glycine-derived, C-3 
unsubstituted thiomorpholinone 33 could not be achieved through the procedure 
developed to prepare 3,5-disubstituted thiomorpholinones. The formation of a mixture 
of imine and enamine isomers was reported to be successful but the final reduction step 
to the unsubstituted thiomorpholinone was claimed problematic, despite many attempts 
being carried out, as all attempts ended with the thiomorpholinone dimer.
2
 At this stage, 
it was therefore decided to focus on developing an alternative synthetic route to obtain 
glycine thiomorpholinones 32 and 33 although it seemed likely that the lack of steric 
hindrance at C-3 would present a great challenge to access the parent thiomorpholinone 
templates.  
In this study, several alternative synthetic routes were explored to access the C-3 
unsubstituted thiomorpholinone system including lactone ring opening, Mitsunobu 








2.1 Ring opening of the morpholinone template and Mitsunobu reaction 
It was planned to use monosubstituted 5(S)-phenylmorpholinone 34 as a model 
substrate for the conversion to 5(S)-phenylthiomorpholinone 32.  
 
Starting material 34 was prepared by the standard procedure,
3
 dissolving (S)-2-
phenylglycinol and N,N-diisopropylethylamine in anhydrous acetonitrile under an 
atmosphere of nitrogen (Scheme 2.1). To this was then added a solution of phenyl 
bromoacetate in anhydrous acetonitrile drop-wise over 10 minutes and the mixture was 
subsequently stirred for 24 hours at room temperature and concentrated under reduced 
pressure to give the crude product 34 as a colourless gum. 
 
         
Scheme 2.1 (i) Phenyl bromoacetate, DIPEA, CH3CN, room temperature, 24 hours  
 
The crude product 34 was then subjected to purification. Several attempts were 
performed to purify the crude product by column chromatography on silica, eluting 
with petroleum ether - diethyl ether (2 : 1) and also crystallization from ethyl acetate. 
However, the desired compound was found to have decomposed after both attempted 
purification procedures. It is known that the target compound is sensitive to acidic 
conditions and also that heating crude material to more than 40 
o
C can promote 









Scheme 2.2 Dimerization of 34 to diketopiperazine 35 
 
Subsequently, when the column chromatography was repeated, approximately 2 cm of 
anhydrous potassium carbonate was added to the top of a column of Florisil
® 
to attempt 
to neutralize any acid in the crude material before elution. The crude material 34 was 
immediately loaded onto the column to avoid dimerization of 34 to 35
3
 and the column 
eluted with petroleum ether – diethyl ether (1 : 2) to remove impurities followed by 
acetone to elute 34 in 70 % yield as a pale yellow oil.  
Evidence that 5(S)-phenylmorpholinone 34 had been successfully synthesized was 
based on observation of the characteristic pair of double doublets at δ 4.42 ppm (J = 
11.0 Hz, J’ = 4.5 Hz) and δ 4.20 ppm (J = 11.0 Hz, J’ = 4.0 Hz), and a apparent triplet 
at δ 4.31 ppm (J = 11.0 Hz) corresponding to the ABX system at C-5 and C-6 of the 
desired product (Figure 2.1). The AB protons appeared at δ 3.98 ppm (J = 18.0 Hz) and 
δ 3.86 ppm (J = 18.0 Hz) as two doublets. A mass ion peak of [MH
+
] at 178.0863 gave 








H NMR spectrum of 5(S)-phenylmorpholinone 34 in CDCl3 
The N-protection of 34 was performed immediately with di-tert-butyl dicarbonate 2 
based on the method reported by Dellaria and Santarsiero
3
 to avoid any loss due to 
dimerization (Scheme 2.3). The 5(S)-phenylmorpholinone 34, di-tert-butyl dicarbonate 
2 and triethylamine were dissolved in diethyl ether at room temperature and the mixture 
left for 6 hours. The reaction mixture was then worked up and purified over silica, 
eluting with diethyl ether, to afford N-Boc-5(S)-phenylmorpholinone 36 as a white solid 
in 58 % yield. 
 






Boc-protected morpholinone 36 gave broadened signals on recording the 400 MHz 
NMR spectrum, considered to be due to the restricted rotation of the acyl group 
attached to the nitrogen. An attempt at further characterization at 500 MHz NMR at 
elevated temperatures from 25 
o
C to 85 
o
C was able to improve the appearance of the 





H NMR spectra of N-Boc-5(S)-phenylmorpholinone 36 in DMSOd6 at 
variable temperature on 500 MHz (Region from 4.0 to 5.5 ppm expanded; the AB and 





Variable temperature facilities were not available on the two 400 MHz spectrometers, 
but at the higher field strength and at 85 
o
C, the broad signals that appeared centred at δ 
4.64 ppm and δ 4.48 ppm were simplified into two double doublets at δ 4.64 ppm (J = 
8.0 Hz, J’ = 4.0 Hz) and δ 4.47 ppm (J = 12.0 Hz, J’ = 4.0 Hz) and the broad resonance 
centred at δ 5.05 ppm  became a broad triplet resonating at δ 5.05 ppm (J = 4.0 Hz) 
corresponding to the ABX system for the protons at C-5 and C-6 (Figure 2.3). Two 
doublets were also observed centred on δ 4.43 ppm (J = 12.0 Hz) and δ 4.31 ppm (J = 
12.0 Hz), indicating the presence of the AB system at C-3. All ABX and AB protons of 
36 were shifted downfield from the parent compound 34 due to the deshielding effect of 
the Boc group. So, despite having to use a greater field strength, analysing at higher 
temperature improved the 
1
H NMR spectrum of 36, causing the broad signals to 
become more defined and separated. A new carbonyl carbon resonance appeared at δ 
154.0 ppm in addition to that at δ 168.8 ppm in the 
13
C NMR spectrum signifying the 
presence of the Boc-carbonyl group. Two strong absorptions at 1768 cm
-1
 and 1700 cm
-
1
 in the IR spectrum provided further support for the presence of two carbonyl groups. 
A mass ion at 276.1241 [MH
-
] gave additional evidence that the Boc protection of 5(S)-







H NMR spectrum of N-Boc-5(S)-phenylmorpholinone 36 in DMSOd6 at 85 
o
C at 500 MHz  
N-Protection with the Fmoc protecting group was carried out as well as N-Boc 
protection, to give more options in our synthetic approach going forward, as Boc and 
Fmoc protecting groups demonstrate orthogonal reactivity under acidic and basic 
conditions  respectively. The N-Fmoc protection was carried out by stirring a mixture of 
morpholinone 34 with Fmoc-Cl and a suspension of K2CO3 in dichloromethane to give 
N-Fmoc-5(S)-phenylmorpholinone 37 in 74 % yield (Scheme 2.4).  
 




Once again, undefined broadened resonances were observed in the
 1
H NMR spectrum 
analysed at room temperature at 400 MHz. Analysis at variable temperature at 500 





H NMR spectrum of N-Fmoc-5(S)-phenylmorpholinone 37 in DMSOd6 at 
variable temperature at 500 MHz (Region from 4.0 to 5.5 ppm expanded showing 
partial resolution of the ABX and AB systems) 
At 85 
o
C, the ABX protons for C-5 and C-6 could be partially resolved into a broad 
triplet at δ 5.05 ppm (J = 4.0 Hz) and two double doublets at δ 4.65 ppm (J = 12.0 Hz, 
J’ = 4.0 Hz) and δ 4.47 ppm (J = 12.0 Hz, J’ = 4.0 Hz) (Figure 2.4; Figure 2.5). All the 
ABX resonances were shifted downfield compared to the parent compound 34, as with 




Fmoc group. The two AB protons could be detected as partially resolved mutually 
coupled doublets centred on δ 4.42 ppm (J = 16.0 Hz) and δ 4.24 ppm (J = 16.0 Hz). 
Mass spectrometry further supported the formation of N-Fmoc-5(S)-
phenylmorpholinone 37 with a molecular ion at 422.1362 [MNa
+




H NMR spectrum of N-Fmoc-5(S)-phenylmorpholinone 37 in DMSOd6 at 
85 
o
C at 500 MHz 
The key step for the next stage was lactone ring opening. This step posed a great 
challenge as the chosen reagent should be able to cleave the ester without stripping off 
the protecting group. Our initial attempts at opening the morpholinone 36 template with 
benzyl mercaptan and installing sulfur in one go by adapting Lumma’s methodology 
failed.
4
 Our attention then turned to the use of iodotrimethylsilane (TMSI) based on the 






 After several unsuccessful attempts, the ring cleavage of 36 was finally induced with 
TMSI in CHCl3 when the reaction mixture was heated to reflux at 48 
o
C for 24 hours to 
afford iodo acid 38, but in a disappointing 12 % yield. However, the Boc-protecting 
group was also removed under these conditions. Under less forcing conditions, the ring 
opening failed; reaction at room temperature, even after five days, leaving the starting 
material untouched.  
 
Scheme 2.5 (i) TMSI, CHCl3, 48 
o
C, 24 hours 
Three apparent triplets at δ 5.05 ppm (J = 8.5 Hz), δ 4.72 ppm (J = 8.5 Hz) and δ 4.16 
ppm (J = 8.5 Hz) signified the presence of the freely rotating –CH–CH2–  system and 
two doublets at 4.32 ppm (J = 18.5 Hz) and 3.42 ppm (J = 18.5 Hz) indicated the AB 
system of iodoacid 38. The mass ion at 305.9985 [MH
+
] gave further support that 
iodoacid 38 had been isolated. Unfortunately, we found that the ring opening only 
occurred at 48 
o
C and the Boc-protecting group was easily removed at temperatures as 
low as 38 
o
C. Therefore, we decided to discontinue this approach to 38 due to the poor 
yield at an early stage and the need for reprotection of the nitrogen.  
A similar ring opening procedure was performed on 37 by refluxing with TMSI but all 
attempts ended up with recovered starting material, despite several attempts having 
been carried out. Heating 37 with TMSI even at 98 
o
C overnight still gave mostly 




trace from mass spectrometry with the molecular ion peak at 528.0687 [MH
+
] being 
present when the crude product mixture was analysed. However, from this experiment, 
it was found that N-Fmoc protection could withstand high temperatures, giving us more 
options for further attempts at lactone ring opening. 
 
Scheme 2.5 (i) TMSI, CHCl3, 98 
o
C, 24 hours  
Therefore, we decided to change our strategy by converting the protected morpholinone 
to opened -hydroxy methyl ester under basic conditions following an adaption of 
Corey’s methodology.
6
 With a large excess of methanol, the nucleophilic ring opening 
was carried out at room temperature for 24 hours in the presence of 6.0 equivalents of 
triethylamine to give crude -hydroxy methyl ester as a colourless oil. Attempts at 
purification of the crude material over silica, eluting with petroleum ether – diethyl 
ether (1 : 2) gave slightly impure 40 in ~76 % yield along with some starting material 





Scheme 2.6 (i) MeOH, Et3N, room temperature, 24 hours 
The methanolysis of 36 was then extended from 24 hours to 48 hours and 72 hours, 
with the reaction being monitored by 
1
H NMR spectroscopy, based on the decrease of 
the proton resonance in 36 at δ 4.97 ppm (J = 4.0 Hz) (Figure 2.6). However, this 
showed that there was no significant change in the ratio of 36 and 40 over that period of 
time suggesting that both 36 and 40 exist in equilibrium under these conditions. This 
conclusion was supported by Choji and Kazuo, who reported that several morpholin-2-
one derivatives exist in equilibrium with their open chain methyl esters during 
methanolysis, with the lactone being favoured by increased ring substitution, most 










H NMR spectra of a mixture of morpholinone 36 and -hydroxy methyl 
ester 40 in DMSOd6, range  δ 5.50 ppm to δ 4.85 ppm, after methanolysis for 24, 48 
and 72 hours  
The partial success of ring opening resulting in conversion to -hydroxy methyl ester 40 
was indicated by a singlet appearing at δ 3.58 ppm (Figure 2.7) revealing the presence 
of the methyl ester and this was supported by a mass ion observed at 332.1468 [MNa
+
].  
A broad absorption centred on 3486 cm
-1
 in the IR spectrum, corresponding to the free 







H NMR spectrum of a mixture of -hydroxy methyl ester 40 and N-Boc-5-
phenylmorpholinone 36 in DMSOd6 
For the sulfur introduction in the next step, we were considering an approach that would 
not require any heating as our previous work had indicated that the Boc group could not 
withstand high temperatures in this system.  Thus, with -hydroxy methyl ester 40 in 
hand, we decided to apply a Mitsunobu reaction procedure to attempt to prepare the -
thioacetate methyl ester at temperatures from 0 
o







Scheme 2.7 (i) DIAD, triphenylphosphine, dry THF, 0 
o
C, 30 minutes, N2 atmosphere 
(ii) thioacetic acid, dry THF, 0 
o
C, 1 hour, room temperature, 24 hours, N2 atmosphere  
Treatment of -hydroxyl methyl ester 40 with thioacetic acid, in the presence of 
triphenylphosphine and diisopropylazodicarboxylate (DIAD) afforded thioacetate 
methyl ester 41 as a yellow oil in 40 % yield after 24 hours. The reaction required 
anhydrous THF and an inert atmosphere for the DIAD to be reduced and this could be 
observed when a milky mixture was formed after about 15 minutes. Separation of 
thioacetate methyl ester 41 from the triphenylphosphine oxide and hydrazine side 
products was best achieved by column chromatography and slow elution with hexane – 
ethyl acetate (7 : 1).  In the beginning, it proved difficult to separate 41 from 
triphenylphosphine oxide as both compounds had similar Rf values of 0.3 and 0.4 
respectively in hexane – ethyl acetate (4:1). Trituration with dichloromethane and 
hexane to precipitate triphenylphosphine oxide followed by purification through 
column chromatography using hexane – ethyl acetate (4 : 1) were also tried, but 41 
could only been obtained in very poor yield and purity. Fortunately, chromatography on 
silica using the less polar solvent combination of hexane – ethyl acetate (7 : 1) 
successfully afforded pure 41 as a yellow oil in a yield of 40 %. However, prior to 
carrying out the column chromatography, the crude product required around 20 – 25 




Heating to speed up the dissolution rate did not help as a white precipitate would then 
form on top of the column during elution, rendering the column ineffective.  
A singlet observed at δ 2.33 ppm in the 
1
H NMR spectrum signified the presence of an 
acylthio group in 41 (Figure 2.8). An ABX system was indicated by the presence of a 
broadened triplet at δ 5.54 ppm (J = 8.0 Hz) and a broad resonance integrating to two 
protons at δ 3.44 – 3.38 ppm. Two signals resonating at δ 3.79 ppm (J = 16.0 Hz) as a 
doublet and at δ 3.56 ppm (J = 16.0 Hz) as a broad doublet could be assigned to the AB 




H COSY NMR spectrum, there were correlation peaks 
among the ABX protons as well as between the AB protons indicating these couplings 
more clearly. The presence of a carbonyl carbon resonance at δ 195.4 ppm on the 
13
C 
NMR spectrum in addition to the two existing carbonyl carbons at δ 170.7 ppm and δ 
154.9 ppm provided further support for the formation of 41. Finally, mass spectrometry 
confirmed the structure with mass ions observed at 368.1524 [MH
+
] and 390.1346 
[MNa
+
], matching with the desired thioacetate methyl ester 41. In addition, mass ions at 
279.0933 [MH
+
] and 205.1180 [MH
+
] for triphenylphosphine oxide and the hydrazine 
from the other fractions respectively suggested those side products were obtained 







H NMR spectrum of N-Boc-thioacetate methyl ester 41 in CDCl3 
The thioacetate methyl ester 41 was then hydrolysed with lithium hydroxide under an 
atmosphere of nitrogen overnight to give crude thiol acid 42 (Scheme 2.8). The 
purification of crude thiol acid was carried out using hexane – ethyl acetate (4 : 1) on 
silica with the addition of 1 %  formic acid to the solvent system to facilitate elution of 
the relatively polar thioacid from the column  (TLC Rf value of 0.2 in this solvent). 






Scheme 2.8 (i) LiOH, water, i-PrOH, room temperature, overnight 
The absence of singlets at δ 2.34 ppm and δ 3.61 ppm in the 
1
H NMR spectrum showed 
that the acyl and methoxy groups respectively had been completely removed (Figure 
2.9). The ABX signals were detected at δ 5.28 ppm (J = 8.0 Hz) as a triplet and centred 
on δ 3.09 ppm as a broad signal. Furthermore, two doublets at δ 3.63 ppm (J = 17.5 Hz) 
and δ 3.55 ppm (J = 17.5 Hz) could be assigned to the AB system of 42. Further 
evidence for mutual coupling within these ABX and AB multiplets was based on the 




H COSY NMR spectrum. The absence of a carbonyl 
carbon resonance at δ 195.4 ppm and observation of a methoxyl carbon resonance at δ 
70.6 ppm in the 
13
C NMR spectrum provided further evidence for the removal of the 
acyl and methoxy groups. All of this was consistent with the observation of a mass ion 
peak at 312.1264 [MH
+
] and 334.1084 [MNa
+







H NMR spectrum of N-Boc- thioacid 42 in DMSOd6 
For the initial attempt to complete the final step of thiolactonization, we considered 
dicyclohexylcarbodiimide as the condensing agent. Other approaches for thiolacid ring 
closure using 10-camphorsulfonic acid or tosylic acid required heating to reflux at 110 
o
C, which could not be applied to our N-Boc protected compound.
10,11
 Sixty years ago, 
Woodward et al. demonstrated that treatment of hydroxyacids with DCC in the 
presence of pyridine resulted in very effective conditions for lactonization.
12,13
 
Furthermore, in 1969, Steglich and Höfle demonstrated that 4-dimethylaminopyridine 
(DMAP) was superior to pyridine.
14
  Therefore, the cyclization of thiol acid 42 was 
performed by reacting it with DCC in dichloromethane at 0 
o
C for 15 minutes before 
adding DMAP and leaving the mixture at room temperature overnight (Scheme 2.9). 
The formation of a white precipitate, presumed to be dicyclohexyl urea 6, was observed 
and the resulting mixture was filtered with suction through Celite
®




three times with dichloromethane and the filtrate concentrated to give the  crude 
cyclized product as a yellow oil. Purification of the crude product over silica, eluting 
with hexane – ethyl acetate (4 : 1), afforded 43 as a yellow oil in 55 % yield. 
 
Scheme 2.9 (i) DCC, CH2Cl2, 0 
o
C, 15 minutes (ii) DMAP, room temperature overnight 
As expected, Boc-protected thiomorpholinone 43 gave broadened signals on 
1
H NMR 
analysis at 400 MHz, once again requiring further analysis at variable temperature. A 
sample, dissolved in DMSOd6, was analysed from 25 
o
C to 85 
o
C at 500 MHz (Figure 
2.10), with analysis at 85 
o
C giving a spectrum in which the resonances had become 








H NMR spectra of N-Boc-protected thiomorpholinone 43 in DMSOd6 at 
variable temperature at 500 MHz (region from 3.4 to 5.3 ppm expanded) 
Two broad ABX signals resonating at δ 5.02 ppm and δ 3.65 – 3.56 ppm in the 400 
MHz NMR spectrum were simplified into a broadened triplet at δ 5.14 ppm (J = 7.0 
Hz) and a broad doublet at δ 3.57 (J = 7.0 Hz), integrating to one proton and two 
protons respectively (Figure 2.11). Two doublets at δ 4.52 ppm (J = 16.0 Hz) and δ 4.33 
ppm (J = 16.0 Hz) were also observed, corresponding to the AB system. The 
appearance of a resonance at δ 200.2 ppm in the 
13
C NMR spectrum that could be 
assigned to a thiolactone further suggested that the ring closure had occurred. This was 
further supported by an absorption at 1156 cm
-1
 in the infra-red spectrum that revealed 
the presence of the C-S-C bond of the lactone ring, while strong overlapping 
absorptions around 1697 cm
-1
 signified the existence of the thiolactone and Boc 




that showed a molecular ion at 316.0978 [MNa
+
], also indicating that N-Boc-protected 




H NMR spectrum of N-Boc-5(S)-phenylthiomorpholinone 43 in DMSOd6 
at 85 
o
C at 500 MHz  
Removal of the Boc protecting group from Boc-thiomorpholinone 43 was conveniently 
achieved using 50 % (v/v) trifluoroacetic acid in dichloromethane (Scheme 2.10). The 
desired 5-phenylthiomorpholinone 32 was obtained as a yellow oil in 81 % yield. The 
deprotection was also examined using 4 M HCl in dioxane as these conditions were 
reported to improve the yields and lead to shorter reaction times.
15
 However, this 
resulted in a lower yield than trifluoroacetic acid – dichloromethane (1 : 1) mixture (42 







Scheme 2.10 (i) TFA, CH2Cl2, 0 
o
C, 30 minutes, room temperature, 1 hour 30 minutes 
The disappearance of the resonance at δ 1.26 ppm in the 
1
H NMR spectrum showed that 
the Boc group had been completely removed (Figure 2.12). The formation of 32 was 
verified by the presence of the thiomorpholinone characteristic resonances in the 
1
H 
NMR spectrum, with two double doublets at δ 4.24 ppm (J = 11.0 Hz, J’ = 3.5 Hz) and 
δ 3.19 ppm (J = 12.0 Hz, J’ = 3.5 Hz) and a triplet at δ 3.48 ppm (J = 12.0 Hz) 
corresponding to the ABX system. All three ABX protons were shifted upfield in 
comparison to the N-Boc precursor 43. In addition, the two AB coupled protons had 
also shifted upfield to δ 3.86 ppm (J = 17.5 Hz) and δ 3.81 ppm (J = 17.5 Hz) due to the 
removal of the deshielding effect of the N–Boc group. The absence of resonances due to 
the Boc carbonyl carbon and tert-butyl carbonyl carbon in the 
13
C NMR spectrum of 43 
at δ 154.7 ppm and δ 28.2 ppm respectively provided more support for the removal of 
the Boc protecting group. Furthermore, the IR spectrum showed a broad N-H stretching 
centred around 3320 cm
-1
, indicating the presence of a free secondary amine, and a 
single carbonyl stretching absorption at 1664 cm
-1
. Final evidence came from the mass 
spectrum, with a molecular ion observed at 194.0634 [MH
+
] and so we were able to 










H NMR spectrum of glycine derived thiomorpholinone 32 in CDCl3 
 
It is important to note that the N-protection was essential throughout the synthetic route 
to ensure the success of template preparation. This approach provides the first synthetic 
route to access the C-3 unsubstituted 5-phenylthiomorpholinone template that could be 
used as a key structural motif for convergent synthesis of peptides containing a glycine 





2.2 Attempts at improvement of the developed method for C-3 unsubstituted  
thiomorpholinone template synthesis 
Overall, a 7 step procedure to access the template of glycine derived thiomorpholinone 
32 had been developed for the first time. The procedure starts with the preparation of 5-
phenylmorpholinone followed by N-Boc protection and then proceeds via nucleophilic 
ring opening of the lactone to give a methyl ester. The sulfur incorporation step is 
performed via Mitsunobu reaction to obtain a thioacetate methyl ester which is then 
hydrolysed to generate the corresponding  thiol acid. Ring closure of the thiol acid is 
achieved using DCC and the synthesis is completed with acidic Boc-deprotection to 
give the desired template 32 (Scheme 2.11).  
 
Scheme 2.11 (i) Phenyl bromoacetate, DIPEA, CH3CN, room temperature, 24 hours (ii) 
Di-tert-butyl dicarbonate, Et3N, EtOAc, room temperature, 6 hours (iii) MeOH, Et3N, 
room temperature, 24 hours (iv) DIAD, triphenylphosphine, dry THF, 0 
o
C, 30 minutes, 
N2 atmosphere, thioacetic acid, dry THF, 0 
o




atmosphere (v) LiOH, water, i-PrOH, room temperature, overnight (vi) DCC, CH2Cl2, 0 
o
C, 15 minutes, DMAP, room temperature, overnight (vii) TFA, CH2Cl2, 0 
o
C, 30 
minutes, room temperature, 1 hour 30 minutes 
Wishing to shorten and improve this pathway, we turned our intention to explore a two 
step procedure to prepare N-Boc-hydroxy methyl ester 40. In this approach, (S)-
phenylglycinol and methyl bromoacetate were reacted according to the methodology 
developed by Panek and Masse.
16
 This N-alkylation procedure successfully generated 
-hydroxy methyl ester 44 as a yellow oil in 76 % yield (Scheme 2.12). This more 
direct preparation of 44 thus allows a more direct access to the glycine-derived 
thiomorpholinone 32 without needing to prepare morpholinone 34.  
 
Scheme 2.12 (i) Methyl bromoacetate, Et3N, dry THF, 0 
o
C to room temperature, 24 
hours 
The success of the N-alkylation step was indicated by a singlet appearing at δ 3.70 ppm 
in the 
1
H NMR spectrum of the product, corresponding to the ester methoxy group 
(Figure 2.14). Three ABX resonances were detected at δ 3.80 ppm (J = 8.5 Hz, J’ = 4.5 
Hz), δ 3.74 ppm (J = 11.0 Hz, J’ = 4.5 Hz) and δ 3.61 ppm (J = 11.0 Hz, J’ = 8.5 Hz) as 
double doublets. Two doublets resonating at δ 3.40 ppm (J = 17.5 Hz) and δ 3.30 ppm 
(J = 17.5 Hz) could be assigned to the AB system. The carbonyl carbon resonance was 
observed at δ 172.7 ppm in the 
13
C NMR spectrum and a molecular ion observed at 
210.1125 [MH
+








H NMR spectrum of N- hydroxy methyl ester 44 in CDCl3 
 
The Boc protection of 44 could then be carried out to prepare N-Boc--hydroxy 
methyl ester 40 and feed in to the following steps to generate the target template. 
Nevertheless, the successful N-alkylation of 44 led us attempt to undertake sulfur 
installation by adapting the Mitsunobu reaction as described in the previous 
protocol without protecting the nitrogen (Scheme 2.13).
9 
After 24 hours of 
reaction, N-thioacetate methyl ester 45 was obtained but, frustratingly, could only 
be isolated in a disappointing 4 % yield. We propose that the low yield can most 
likely be attributed to the strong nucleophilic properties of nitrogen causing most 






Scheme 2.13 (i) DIAD, triphenylphosphine, dry THF, 0 
o
C, 30 minutes, N2 atmosphere, 
thioacetic acid, dry THF, 0 
o
C, 1 hour, room temperature, 24 hours, N2 atmosphere 
Examination of the this material found a new singlet appearing at δ 2.48 ppm in the 
1
H 
NMR spectrum, showing that the sulfur substitution had been successful (Figure 2.15). 
The ABX coupling system resonated at δ 5.18 ppm (J = 7.0) and δ 3.10 ppm as a triplet 
and multiplet respectively. The two protons from the methylene group were observed as 
doublets at δ 3.91 ppm (J = 17.0 Hz) and δ 3.37 ppm (J = 17.0 Hz). The formation of 45 
was further supported by mass spectrometry, which showed a molecular ion peak at 
268.1002 [MH
+











H NMR spectrum of N-thioacetate methyl ester 45 in CDCl3 
 
We then aimed to improve the yield of the sulfur introduction step with N-Boc hydroxy 
methyl ester 40 by converting the hydroxyl group to a mesylate and then treating with 
potassium thioacetate to give thioacetate methyl ester 41. The mesylate substituent is 
well known in organic chemistry as one of better leaving groups.
17 
Thus, 
methanesulfonyl chloride was added dropwise to a solution of 40 and DIPEA in 
dichloromethane at 0 
o
C (Scheme 2.14). The reaction mixture was stirred for an hour at 
0 
o
C and stirring was then continued for another hour at room temperature. 








Scheme 2.14 (i) Methanesulfonyl chloride, DIPEA, DCM, 0 
o
C, 1 hour, room 
temperature, 1 hour 
The conversion of the hydroxyl group to its corresponding mesylate was indicated by 
the appearance of an additional singlet resonance in the 
1
H NMR spectrum at δ 3.68 
ppm (Figure 2.16). The presence of the ABX system was verified by three quasi triplets 
resonating at δ 5.06 ppm (J = 8.5 Hz), δ 4.72 ppm (J = 8.5 Hz) and δ 4.15 ppm (J = 8.0 
Hz). Two doublets appeared at δ 4.30 ppm (J = 18.0 Hz) and δ 3.39 (J = 18.0 Hz) 
signifying the presence of the AB system. The molecular ion peak observed at 410.1244 
[MNa
+
] in the mass spectrum gave further evidence to confirm that mesylate 46 had 







H NMR spectrum of N-Boc-mesylate methyl ester 46 in CDCl3 
Due to worries about stability, mesylate 46 was used directly for the next step without 
purification. In this step, mesylate 46 was dissolved in DMF and the solution 
subsequently heated with potassium thioacetate at 40 
o
C for 16 hours (Scheme 2.15).
18
 
After work up and purification over silica, eluting with hexane – ethyl acetate (4 : 1), 
none of the desired product could be isolated. We therefore decided to discontinue this 
approach due to the poor yield during the formation of the mesylate. For future work, 
the use of other leaving groups to replace the mesylate should be continued to 
investigate whether this could improve the yield.  
 
Scheme 2.15 (i) Potassium thioacetate, DMF, 40 
o




2.3 Approaches towards the 5-(4-methoxyphenyl) thiomorpholinone template 
After the successful glycine derived thiomorpholinone 32 generation, the next plan was 
to incorporate a methoxy group onto the 5-aryl substituent. In a previous study, the t-
butyl, Fmoc protecting group and phenyl substituent on the morpholinone-based 
peptide precursor were all removed in one pot under harsh conditions using lithium in 
liquid ammonia after formation of the peptide linkage (Scheme 1.25 and 1.26).
19
 This 
approach was demonstrated by the Harwood group when preparing the L-ala-L-ala-L-
ala and L-ala-D-ala-L-ala tripeptides.
20
 The incorporation of a 5-(4-methoxyphenyl) 
group into the thiomorpholinone system would potentially allow for much more mild 
debenzylation conditions after amide bond formation.  
To achieve this target, we decided to use 4-methoxyphenylglycinol 47 as a starting 
material, which could be prepared through a four step procedure as summarized in 
Scheme 2.16. The preparation of starting material began with amino group protection of 
commercially available 4-hydroxyphenylglycine with di-tert-butyl dicarbonate 2 in the 






Scheme 2.16 (i) Di-tert-butyl dicarbonate, NaOH, H2O – dioxane (2 : 1), room 
temperature, 4 hours (ii) MeI, K2CO3, acetone, 50 
o
C, 16 hours (iii) NaBH4, LiCl, 
ethanol, 0 
o
C, 10 minutes, THF, room temperature, 3 hours (iv) TFA, CH2Cl2, 0 
o
C, 30 
minutes, room temperature, 90 minutes 
The N-Boc protection of 48 was determined based on the presence of a singlet 
resonance at δ 1.38 ppm (Figure 2.17) in the 
1
H NMR spectrum corresponding to the 
tert-butyl resonance. The successful N-protection was also indicated by the observation 
of a molecular ion peak at 290.0999 [MNa
+











Our next task was to convert the phenol to a methoxy group via O-methylation with 
iodomethane according to the method developed by Leermann et al.
21 
Treatment of 48 
with iodomethane in the presence of K2CO3 at 50 
o
C for 16 hours successfully led to 
methoxy installation on the phenyl ring of 49 as well as esterification of the carboxylic 
acid.  Purification of the crude material over silica, eluting with petroleum ether – 
diethyl ether (2 : 1), furnished 49 as a white solid in 41 % yield.  The presence of two 
singlets at δ 3.79 ppm and δ 3.71 ppm in the 
1
H NMR spectrum indicated the existence 
of the two methoxy groups in 49 (Figure 2.18).  Further evidence was obtained from 
mass spectrometry, with a molecular ion at 318.1312 [MNa
+










The resulting methyl ester 49 was then reduced to its corresponding alcohol with 
lithium aluminium hydride to give N-Boc-4-methoxyphenylglycinol 50 as a white solid 
in 65 % yield. However, previous work had shown that the reduction of a similar ester 
using NaBH4 as reducing agent could afford the corresponding alcohol in higher 
yield.
22 
By adapting this approach, a solution of 49 in THF was added to a suspension 
of NaBH4 in ethanol at room temperature for 3 hours, in the presence of LiCl to 
enhance the reduction efficiency of NaBH4 through coordination of Li to the carbonyl 
oxygen; thus increasing the rate of hydride attack.
23
 After work up and purification over 
silica, eluting with hexane – ethyl acetate (4 : 1), the desired reduced N-Boc-4-
methoxyphenylglycinol 50 was obtained as a white solid in an improved yield of 80 %. 
The structure was confirmed based on the absence of the methoxy resonance at δ 3.71 
ppm in the 
1
H NMR spectrum reflecting the transformation of the ester to the glycinol 
(Figure 2.19). A broad absorption in the IR spectrum centred at 3402 cm
-1
 indicated the 
presence of the hydroxy group in 50. Finally, analysis by mass spectrometry provided 
more support, with a molecular ion peak detected at 268.1542 [MH
+
] and 290.1363 
[MNa
+












Subsequently, Boc deprotection of 50 was carried out with 50 % (v/v) trifluoroacetic 
acid in dichloromethane to give the desired starting material 4-methoxyphenylglycinol 
47 as a yellow oil in 85 % yield. The disappearance of the broad singlet at δ 1.43 ppm 
from the 
1
H NMR spectrum indicated the removal of the Boc group (Figure 2.20). 
Another broad signal appeared at δ 1.85 ppm could be assigned to the free amino and 
hydroxy group protons and free water in the solvent. A characteristic of the ABX 
system showed broad resonances at δ 4.06 ppm and δ 3.74 ppm and at δ 3.60 ppm (J = 
9.5 Hz) as an apparent triplet. Mass spectrometry confirmed the formation of 47 with a 







H NMR spectrum of 4-methoxyphenylglycinol 47 in CDCl3 
With 47 in hand, we were keen to consider a shorter pathway to access the glycine 




Following the earlier approach with the phenyl analogue, 47 was treated with methyl 
bromoacetate in dry THF at 0 
o
C and the mixture was allowed to warm to room 
temperature over 24 hours (Scheme 2.17). The crude material was purified over silica, 
eluting with hexane – ethyl acetate (1 : 1), until 51 began to elute; then ethyl acetate 
was used for complete elution of the relatively polar 51. This N-alkylation procedure 
successfully generated hydroxy methyl ester 51, but in a disappointing 15 % yield.  The 
procedure was repeated by increasing the amount of methyl bromoacetate to 2.0 and 2.5 
equivalents but this reaction ended with an equally poor yield of the target compound. 
For future attempts at improving the yield, it would be worthwhile examining more 
basic conditions for the N-alkylation reaction by increasing the amount of triethylamine 
to facilitate the nitrogen attack on the methyl bromoacetate. 
 
Scheme 2.17 (i) Methyl bromoacetate, Et3N, dry THF, 0 
o
C to room temperature, 24 
hours 
Evidence for the successful N-alkylation was based on the appearance of an AB 
resonance as two doublets at δ 3.31 ppm (J = 17.5 Hz) and δ 3.21 ppm (J = 17.5 Hz) 
and an additional methoxy singlet resonating at δ 3.62 ppm corresponding to the methyl 
ester (Figure 2.21). The carbonyl carbon resonance observed at δ 173.1 ppm in the 
13
C 
NMR spectrum gave further evidence for the presence of an ester. Mass spectrometric 
analysis of 51 was consistent with the proposed structure, having molecular ions at 
240.1230 [MH
+










H NMR spectrum of 4-methoxyphenyl ester 51 in CDCl3 
The N-Boc protection of 51 then proceeded to give 52 following the standard procedure 
(Scheme 2.17).
3
 The presence of a broad singlet at δ 1.35 ppm in the 
1
H NMR spectrum 
showed that N-Boc protection of 52 had been achieved and this was also supported by 






Unfortunately, this synthetic route remains incomplete due to lack of time. For future 
work in developing this synthetic route, if 52 could tolerate the synthetic route 
developed to access glycine thiomorpholinone (Scheme 2.11), it most probably requires 
four more steps along similar lines as already established, and would permit access to 







Scheme 2.17 (i) Di-tert-butyl dicarbonate, Et3N, EtOAc, room temperature, 6 hours 
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Other attempts to access C3-unsubstituted thiomorpholinone 
In an attempt to access the C-3 unsubstituted thiomorpholinone, several routes were 
explored. In one approach, we aimed to construct amino thiol protected acid precursor 
53 via reductive amination before ring-closing to access the desired thiomorpholinone 
template (Scheme 3.1). The details of this pathway are discussed in Section 3.1. 
 
Scheme 3.1 Proposed access to the 3-unsubstituted thiomorpholinone template via 
reductive amination (i) glycine, NaCNBH3, reflux, 24 hours
1
 (ii) trifluoroacetic 
anhydride, reflux, 2 hours
2  
Another potential pathway planned to access the desired thiomorpholinone template 
was by thionation of the corresponding morpholinone. In principle, this approach 
required only two more steps from 37 to give thionated product 54 followed by 
isomerisation to give thiomorpholinone 55 (Scheme 3.2). Several thionating agents 







Scheme 3.2 Proposed access to thiomorpholinone 55 via thionation (i) Lawesson's 
Reagent or P4S10
3





3.1 Thiomorpholinone synthesis via reductive amination 
For this synthetic pathway, the thiol group was planned to be introduced earlier in the 
synthetic sequence. To this end, a benzyl mercaptan was chosen as a source of the thiol 
group as this prevented the thiol interfering during the reductive amination. To achieve 
this, we considered the reductive amination reaction between thiobenzyl acetophenone 
56 with glycine to generate thiobenzyl acid skeleton 53. The starting material 56 was 
prepared by adding benzylthiol dropwise to a solution of 2-bromoacetophenone and 
triethylamine in acetone cooled in an ice – salt bath (Scheme 3.3).
5
 The crude product 
was purified over silica eluting with hexane – ethyl acetate (4 : 1) to give 56 as a white 
solid in an excellent 93 % yield.   
 




The incorporation of the thiobenzyl group in 56 was indicated by an additional singlet 
appearing at δ 3.68 ppm in the 
1
H NMR spectrum corresponding to the presence of the -
SCH2- group (Figure 3.1). The preparation of 56 was also supported from the mass 






H NMR spectrum of thiobenzyl 56 in CDCl3 
With starting material 56 in hand, the reductive amination was carried out with glycine 
using sodium cyanoborohydride as the reducing agent (Scheme 3.4).
1
 The mixture was 
heated to reflux for 24 hours, but it was found that the starting material 56 had simply 





Scheme 3.4 (i) glycine, NaCNBH3, reflux, 24 hours 
 
The reduction to alcohol 58 was revealed by the presence of an ABX system with 
double doublets observed at δ 4.66 ppm (J  =  9.0 Hz, J’ = 3.5 Hz), δ 2.78 ppm (J = 
14.0 Hz, J’ = 3.5 Hz) and δ 2.65 ppm (J = 14.0 Hz, J’ = 9.0 Hz). A molecular ion at 
227.0890 [(M-H2O) H
+
] in the mass spectrum further supported the fact that alcohol 58 







H NMR spectrum of reduced product 58 in CDCl3 
Another option that could be carried out would be the amination of thiobenzyl 
acetophenone 56 to prepare aminothioether 59 that could undergo an alternative 
reductive amination reaction with glyoxylic acid to generate the thiobenzyl acid 




Scheme 3.5 (i) ammonium acetate, NaCNBH3, methanol, reflux, 24 hours (ii) glyoxylic 




Thus, treatment of 56 with ammonium acetate and sodium cyanoborohydride 
successfully produced aminothioether 59 as a yellow oil in 73 % yield. The success of 
this amination was signified by an ABX system appearing at δ 2.86 – 2.76 ppm as a 
two-proton multiplet and a one-proton double doublet at δ 4.08 ppm (J = 8.0 Hz, J’ = 
6.0 Hz) occurring upfield compared to alcohol 58 (Figure 3.3). The formation of 
aminothioether 59 was further supported by mass spectrometric analysis with a 






H NMR spectrum of aminothioether 59 in CDCl3 
The next step was to perform the second reductive amination reaction between 
aminothioether 59 and glyoxylic acid using the same reducing system.
6
 However, the 
reaction failed, despite many attempts. We then decided to perform the N-alkylation 




alternative precursor 60 with the acid protected as a t-butyl ester (Scheme 3.6). To this 
end, tert-butyl bromoacetate was added dropwise to a solution of aminothioether 59 and 




 The mixture was allowed to warm at room 
temperature and stirred overnight. After workup and purification over silica, eluting 
with hexane - ethyl acetate (4 : 1), the desired N-alkylated product 60 was obtained as a 
yellow oil in 28 % yield. 
 
Scheme 3.6 (i) tert-butyl bromoacetate, Et3N, dry THF, 0 
o
C to room temperature, 
overnight 
The presence of an AB coupling system in the 
1
H NMR spectrum of the purified 
product at δ 3.19 ppm (J = 17.5 Hz) and δ 2.99 ppm (J = 17.5 Hz) indicated that the 
desired N-alkylated precursor had been obtained (Figure 3.4). Furthermore, signals 
resonating at δ 3.72 ppm as a multiplet and double doublets at δ 2.69 ppm (J = 13.5 Hz, 
J’ = 4.5 Hz) and δ 2.59 ppm (J = 13.5 Hz, J’ = 9.5 Hz) could be assigned to the ABX 
system. Supporting evidence was obtained from the mass spectrum, which showed 
molecular ions at 358.1835 [MH
+
] and 380.1655 [MNa
+









H NMR spectrum of N-alkylated product 60 in CDCl3 
Our next plan was to perform ring closure using TFAA by adapting Ferraris’ 
methodology.
2
 The use of an acidic reagent and heating at 60 
o
C in the procedure led us 
to decide upon N-Fmoc protection for 60 as the Fmoc-protecting group demonstrated 
stability at higher temperatures based on our experience with Fmoc-morpholinone 37, 
as described in Chapter 2. N-Fmoc protection was carried out on 60 with Fmoc-Cl with 
a suspension of K2CO3 in dichloromethane at room temperature overnight (Scheme 
3.7). The crude product was purified over silica, eluting with hexane – ethyl acetate (7 : 
1), to give N-Fmoc tBu glycinate 61 as a yellow oil in 70 % yield. The molecular ion 
observed at 580.2516 [MH
+
] and 602.2336 [MNa
+
] confirmed the success of the N-
Fmoc protection. The removal of the tBu protecting group was then performed using 50 




yellow oil in 70 % yield (Scheme 3.7). The absence of a singlet at δ 1.26 ppm in the 
1
H 
NMR spectrum showed that the t-butyl protecting group had been removed. Further 
supporting evidence was obtained from mass spectrometric analysis, with a molecular 
ion being observed at 546.1710 [MNa
+
], which was consistent with the assigned 
structure 62. 
 
Scheme 3.7 (i) Fmoc-Cl, K2CO3, CH2Cl2, overnight, room temperature (ii) TFA, 
CH2Cl2, 0 
o
C, 30 minutes, room temperature, 1 hour  
At this point in the work, we had already successfully developed a synthetic route to 
access glycine-derived thiomorpholinone starting from 5-phenylmorpholinone as 
described in Chapter 2. We therefore decided to repeat the same procedure to prepare 
N-Fmoc thiobenzyl acid 62 using 4-methoxybromoacetophenone as the starting 
material, with a slight modification in order to introduce the methoxyphenyl group into 
the thiomorpholinone system. The synthetic pathway used to access the 4-





Scheme 3.8 (i) benzyl mercaptan, Et3N, acetone, ice – salt bath, 1 hour (ii) ammonium 
acetate, NaCNBH3, methanol, reflux, 24 hours (iii) O-methyl hydroxylamine 
hydrochloride, pyridine, ethanol, reflux, 2 hours (iv) BH3-THF, THF, 0 
o
C; reflux, 3.5 
hours; reflux → room temperature (v) tert-butyl bromoacetate, Et3N, dry THF, 0 
o
C to 
room temperature, overnight (vi) Fmoc-Cl, K2CO3, CH2Cl2, overnight, room 
temperature (vii) TFA, CH2Cl2, 0 
o
C, 30 minutes, room temperature, 1 hour 
The thiobenzyl substitution reaction was carried out following the previous protocol 
using benzylthiol to give 64 as a white solid in 77 % yield.
5




singlet at δ 3.63 ppm in the 
1
H NMR spectrum indicated the success of the thiobenzyl 
installation and this was supported by mass spectrometric analysis, with quasi 
molecular ions detected at 273.0944 [MH
+
] and 295.0763 [MNa
+
]. In the second step, 
however, the reductive amination on 64 with ammonium acetate only gave the desired 
amino thiobenzyl 65 as a trace product, based on analysis by mass spectrometry with a 
molecular ion peak being observed at 274.1262 [MH
+
].  Instead, it was found that most 
of the starting material had been reduced to alcohol 66. 
 
The formation of alcohol 66 was shown by the appearance of an ABX coupling system 
with double doublets resonating at δ 3.96 ppm (J = 9.0 Hz, J’ = 4.5 Hz), δ 2.71 ppm (J 
= 13.5 Hz, J’ = 4.5 Hz) and δ 2.58 ppm (J = 13.5 Hz, J’ = 9.0 Hz) and was further 










H NMR spectrum of reduced product 66 in CDCl3 
In an alternative approach, we decided to prepare 4-methoxyphenylaminoethyl 
thiobenzyl ether 65 following the procedure developed by Tchertchian et al.
6
 In this 
methodology, 64 was converted to oxime 67 by heating to reflux in ethanol with O-
methyl hydroxylamine hydrochloride and pyridine before reducing to the 
aminothiobenzyl derivative 65 (Scheme 3.8).
6
 In this way, oxime 67 was obtained as a 
colourless oil in 70 % yield, the presence of a new methoxy singlet at δ 3.97 ppm in 
addition to that at δ 3.82 ppm signifying the success of conversion (Figure 3.6).  A 
molecular ion peak detected at 302.1209 [MH
+
] by mass spectrometric analysis gave 







H NMR spectrum of oxime 67 in CDCl3 
Our next task was to reduce the oxime functionality to 4-methoxyphenylamino ethyl 
thiobenzyl ether derivative 65. The reduction was carried out using a solution of BH3-
THF and the mixture was heated to reflux for 3.5 hours (Scheme 3.8).
6
 After work up 
and purification on silica, eluting with ethyl acetate - methanol (4 : 1), the desired 
product 65 was obtained in 87 % yield as a yellow oil. 
The disappearence of the methoxy singlet at δ 3.97 ppm in the 
1
H NMR spectrum 
indicated that the desired reduction had occurred. A characteristic ABX coupling 
system appeared at δ 4.10 ppm (J = 7.0 Hz) as an apparent triplet and at δ 2.94 ppm (J = 
14.0 Hz, J’ = 7.0 Hz) and δ 2.82 ppm (J = 14.0 Hz, J’ = 7.0 Hz) as double doublets 




ion peak observed at 274.1260 [MH
+





H NMR spectrum of 4-(methoxyphenyl)aminothiobenzyl derivative 65 in 
CDCl3 
The N-alkylation of 65 was performed following the same procedure as before, using 
tert-butyl bromoacetate to give 68 as a yellow oil in 65 % yield.
7
 The structure was 
confirmed based on the two doublets detected at δ 3.17 ppm (J = 17.5 Hz) and δ 2.98 
ppm (J = 17.5 Hz) corresponding to the AB resonance system (Figure 3.8). The 
molecular ion peaks observed at 388.1941 [MH
+
] and 410.1760 [MNa
+
] confirmed that 







H NMR spectrum of 4-methoxy N-alkylated product 68 in CDCl3 
The N-Fmoc protection on 68 was subsequently carried out to give 69 in 61 % yield. 
The appearance of a triplet at δ 5.56 ppm (J = 8.0 Hz) and a doublet at δ 2.97 ppm (J = 
8.0 Hz) indicated the success of the N-Fmoc attachment. The tert-butyl removal on 69 
was performed using a similar procedure to previously with 50 % (v/v) trifluoroacetic 
acid in dichloromethane to give 63 in 73 % yield. The absence of a singlet at δ 1.30 
ppm showed that the tert-butyl group had been completely removed. The success of the 
concommitant N-Fmoc protection and tert-butyl removal was supported by mass 
spectrometric analysis with a molecular ion peak at 632.2441 [MH
+
] and 576.1815 
[MNa
+
] being observed for 69 and 63 respectively.  
The cyclisation of 63 was then attempted by adapting the Ferraris procedure,
2
 involving 








their system, the ring closure proceeds by initial generation of the corresponding mixed 
anhydride.
2
 This anhydride is then converted to a sulfonium intermediate that undergoes 
subsequent double elimination to produce the thiolactone (Scheme 3.9).
2
   
 
Scheme 3.9 (i) TFAA, reflux 
Following this protocol, 63 was heated to reflux in trifluoroacetic anhydride for 2 hours 
(Scheme 3.10). The resulting mixture was evaporated in vacuo, quenched with saturated 
NaHCO3 at 0 
o
C, acidified with 1 M HCl and extracted with ethyl acetate. Attempted 
purification of the crude product was carried out over silica with a gradient elution 
starting with hexane - ethyl acetate (4 : 1) and increasing to 100 % ethyl acetate; 
however none of the fractions contained the desired cyclised product. Treatment of 63 







Scheme 3.10 (i) trifluoroacetic anhydride, reflux, 2 hours 
At this stage, we decided to abandon this cyclisation approach. In future attempts, 
alternative procedures for benzyl removal would be worth exploring with 69, where the 
carboxyl group protected as its tert-butyl ester.  
At the same time as attempting to develop approaches proceeding through a reductive 
amination strategy, we also considered thioacetate 71 as an alternative starting material. 
This was prepared by treating 2-bromoacetophenone with potassium thioacetate in THF 
(Scheme 3.11). The mixture was heated at 40 
o
C for 24 hours and after work up, the 
crude product was concentrated in vacuo to give 71 as a yellow oil in 85 % yield. The 
appearance of a new singlet at δ 2.41 ppm in the 
1
H NMR spectrum indicated 
successful of thioacylation (Figure 3.9). The formation of 71 was further confirmed 
from by mass spectrometric analysis with quasi molecular ion peaks being observed at 
195.0474 [MH
+









Scheme 3.11 (i) potassium thioacetate, THF, reflux, 24 hours (ii) 1 M NaOH in MeOH, 




H NMR spectrum of thioacetate 71 in CDCl3 
The thioacetate 71 was then hydrolysed with 1 M NaOH in methanol at room 
temperature for 24 hours to give thioacid 72 as a yellow oil in 55 % yield. The 






H NMR spectrum (Figure 3.10) and a molecular ion peak detected at 153.0367 
[MH
+




H NMR spectrum of thioacid 72 in CDCl3 
Direct reductive amination of 72 was then performed with glycine using sodium 
triacetoxyborohydride (STAB) as the reducing agent. Abdel-Magid et al. reported that 
the use of sodium triacetoxyborohydride in reductive amination of certain ketones could 
give a better yield and fewer side products in comparison to NaBH3CN/MeOH, borane-
pyridine or catalytic hydrogenation.
8
 Therefore, treatment of 72 with glycine using 
STAB as the reducing agent, in the presence of acetic acid as catalyst, was carried out at 
room temperature for 24 hours (Scheme 3.12). The reaction mixture was quenched with 
saturated NaHCO3, extracted into diethyl ether, washed with brine, dried and purified 





Scheme 3.12 Glycine, STAB, acetic acid, room temperature, 24 hours 
The presence of AB and ABX coupling systems in the 
1
H NMR spectrum as two 
doublets (J = 14.0 Hz) at  4.17 ppm and δ 4.10 ppm accompanied by two double 
doublets at  3.11 ppm (J = 14.0 Hz, J’ = 3.0 Hz) and  2.88 ppm (J = 14.0 Hz, J’ = 9.5 
Hz) and a broadened double triplet at  4.91 ppm (J = 9.5 Hz, J’ = 3.0 Hz) led us to 
assume that reductive amination had been successfully achieved (Figure 3.11). Further 




H COSY NMR spectrum indicating the 
cross coupling between the AB and ABX protons.  
However, no molecular ion peak of desired product 73 or any possible dimerised or 
reduced product of 73 could be observed in the mass spectrum. We presume that 73 
exists as zwitterionic compound. According to Jones, the zwitterionic character of 
similar compounds to 73 causes them to be very involatile requiring high temperature 
for vapourization.
9
 Furthermore, several amino acids and peptide derivatives have been 
reported to lose their carboxyl group during mass spectrometric analysis.
10
 From the 
mass spectrum of proposed product 73, a molecular ion peak of 167.0126 [(M-
CO2H)H
+
] was observed supporting the fact that the 73 might have lost its carboxyl 
group during fragmentation. 
At this point, based on the evidence from 
1
H NMR and COSY spectrum, we proposed 
that the product obtained from the reductive amination of 72 with glycine was the 







H NMR spectrum of proposed product 73 in CDCl3 from attempted STAB 
reductive amination of 72 with glycine  
For future work along this synthetic route, it is recommended the protection of the SH 
group is carried out on 72 before proceeding to the reductive amination and the starting 
material containing the 4-methoxyphenyl group should be used. Since the thiol group is 
more sensitive than a hydroxyl group, not just under acidic conditions. but also 
demonstrates instability to basic conditions and oxidizing agents, this protection seems 
likely to be important to ensure the success of the reductive amination.
11
 The thiol 
protection could be performed by preparing the methoxymethyl (MOM) thioether based 
on the procedure suggested by Jae et al. and removed with ZnBr2 and a mercaptan 








approach should need only five steps to access the desired thiomorpholinone via 
precursor 73 following the established synthetic route outlined in Scheme 2.11. 
3.2 Thiomorpholinone synthesis via thionation of morpholinone 
Phosphorus pentasulfide (P4S10) and Lawesson’s reagent are commonly used as 
thionating agents that can convert lactones to thionolactones.
3,13
 Furthermore, in 2006, 
Filippi et al. discovered that boron trifluoride etherate could efficiently catalyse the 
isomerisation of thionolactones to thiolactones.
4
 By adopting both procedures, we were 
interested to explore the thionation reaction to prepare thionomorpholinone 54 and then 
proceed to isomerization to thiomorpholinone 55 as exemplified in Scheme 3.2. Since 
both processes require the use of heating to higher than 80 
o
C in the standard 
procedures, we decided to use N-Fmoc-5(S)-phenylmorpholinone 37 as the starting 
material. 
Following the standard procedure,
3
 37 and Lawesson’s reagent were heated at reflux in 
acetonitrile for 4 hours under an atmosphere of nitrogen (Scheme 3.13). The mixture 
was concentrated in vacuo and purified over silica eluting with hexane - ethyl acetate (4 
: 1), but only starting material was recovered from the reaction. A change of solvent to 








Scheme 3.13 (i) Lawesson's Reagent, MeCN, 80 
o
C, 4 hours, N2 atmosphere (ii) 
Lawesson's Reagent, CH3Ph, 110 
o
C, 24 hours, N2 atmosphere (iii) P2S5, HMDO, 
MeCN, 82 
o
C, 24 hours, N2 atmosphere (iv) P2S5, HMDO, CH3Ph, 108 
o
C, 24 hours, N2 
atmosphere (v) P4S10-pyridine, MeCN, 82 
o
C, 24 hours (vi) P4S10-pyridine, 
dimethylsulfone, 170-175 
o
C, 15 minutes 
Curphey has reported that the use of hexamethyldisiloxane (HMDO) in thionations 
could increase the selectivity of phosphorus pentasulfide (P4S10) to produce 
thionolactones.
14
 Adopting this approach, 37 was heated to reflux with a P4S10–HMDO 
combination in acetonitrile for 3 hours under a nitrogen atmosphere (Scheme 3.13). 
Unfortunately, once again, the starting material remained untouched. The procedure 
was repeated by changing the solvent to toluene but no reaction was observed. In 2011, 
a P4S10-pyridine complex was reported to achieve even more selective  thionations at 
high temperatures (165 – 175 
o
C) at which the Lawesson's reagent would decompose.
15
 
Following this protocol, 37 was heated to reflux with the P4S10-pyridine complex in 
acetonitrile for 24 hours but again gave only recovered starting material. The thionation 
procedure was repeated, but this time at a temperature between 170 – 175 
o
C in 
dimethyl sulfone for 15 minutes.
15
 However, yet again, only starting material was 




On the positive side, even though these thionation procedures failed to give the desired 
thionated product, we have found that N-Fmoc-5(S)-phenylmorpholinone 37 can 
withstand temperatures up to 175 
o
C. As a result of this degree of thermal stability, for 
work in the future, it would be worth attempting a thionation procedure developed by 
Filippi et al. that applies microwave irradiation in the reaction.
16
 The exposure of direct 
microwave irradiation to the reaction mixture under solventless conditions might help 
with the formation of the desired thionomorpholinone.  
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Application of glycine derived thiomorpholinone templates to amide 
bond formation 
After generation of C-3 unsubstituted thiomorpholinone template 32, we decided to 
explore its reactivity towards peptide development. In a previous study, it was shown 
that the N-acylated morpholinone is prevented from intramolecular attack on the 
carbonyl moiety on the lactone ring to form an oxazolone (Scheme 1.21).
1
 Furthermore, 
the study showed that the non-acylated morpholinone was sensitive to attack by 




Scheme 4.1 (i) 1 M HCl, Methanol, reflux, 2 hours, N2 atmosphere 
With the thiolactone function in the thiomorpholinone system, that is known to show  
greater propensity towards nucleophilic attack,
3
  we therefore planned our strategy to 
begin with N-acylation at the nitrogen moiety on the thiomorpholinone template 32, 
circumventing the problem associated with oxazolone formation and then to proceed to 
the C-terminus extension, thus generating the peptide adduct. 
4.1 N-terminus extension 
After deprotection, the glycine derived thiomorpholinone template 32 was ready for 
amide bond generation at the N-terminus. Thus, template 32 was immediately used for 
N-acylation to avoid any loss to dimerization. There are several methods developed for 








 and acyl chlorides.
6
 In a previous study, the N-acylation of 
morpholinone via carbodiimide and phosphonium salt PyBrop was reported to fail.
1
 
However, the N-acylation of morpholinone was demonstrated using N-Fmoc amino acid 
chlorides.
1
 The development of Fmoc-amino acid chloride as coupling agents by 
Carpino allowed the rapid synthesis of smaller peptides under mild conditions without 
loss of chiral integrity.
6
 Following Carpino’s approach, Fmoc-alanine acid chloride 74 
was prepared by reacting N-Fmoc-alanine with thionyl chloride in dry dichloromethane 
for 2 hours under an atmosphere of nitrogen (Scheme 4.2).
6
 The crude product was 
purified over silica eluting with hexane – ethyl acetate (6 : 1) to give 74 as a white solid 
in 60 % yield.  
 
Scheme 4.2 (i) SOCl2, dry dichloromethane, reflux, 2 hours, N2 atmosphere 
The N-terminus peptide extension on glycine derived thiomorpholinone template 32 
was then carried out by adapting Carpino’s approach and that developed by the 
Harwood group.
1
 In this methodology, a solution of Fmoc-alanine acid chloride 74 was 
added drop-wise to a suspension of thiomorpholinone template 32 and Na2CO3 in dry 
dichloromethane and the mixture was left at room temperature overnight (Scheme 4.3). 
The resulting mixture was suction filtered through a short pad of Celite
®
 and the filtrate 
was concentrated and purified over silica, eluting with hexane – ethyl acetate (1 : 1) to 






Scheme 4.3 (i) Fmoc-alanine acid chloride 74, Na2CO3, dry dichloromethane, room 
temperature, overnight, N2 atmosphere 
The success of the peptide coupling was verified by observation of a doublet at δ 1.19 
ppm (J = 7.0 Hz) and a broad signal at δ 4.27 – 4.20 ppm on 
1
H NMR analysis, 
corresponding to the methyl and CH groups of the alanine constituent (Figure 4.1). 
Although not resolved in the 
1
H NMR spectrum, correlation between these two signals 




H COSY NMR spectrum.  The characteristic ABX proton 
coupling system was again shifted downfield from the parent compound 32 to δ 5.38 
ppm (J = 12.5 Hz, J’ = 7.0 Hz) and δ 3.67 – 3.59 ppm, appearing as a double doublet 
and a broad multiplet respectively, indicating that N-acylation had indeed occurred. A 
similar effect was displayed by the AB coupling protons that resonated downfield 
compared to the starting material at δ 4.63 ppm (J = 17.0 Hz) and δ 4.51 ppm (J = 17.0 
Hz). Although, once again poorly resolved in the 
1
H NMR spectrum, the ABX and AB 





COSY NMR spectrum. Further evidence was obtained from the 
13
C NMR spectrum 
with two new carbonyl carbon resonances appearing at δ 171.9 ppm and δ 164.6 ppm, 
reflecting Fmoc-alanine attachment on the N-terminus of thiomorpholinone template 
32. A molecular ion observed at 487.1686 [MH
+
] and 509.1505 [MNa
+
] confirmed that 







H NMR spectrum of dipeptide adduct 75 in DMSOd6 
The 
1
H NMR analysis was repeated at a spectrometer frequency of 500 MHz using 
variable temperature in an attempt to resolve the broad peaks in the region δ 4.24 – 4.15 
ppm (Figure 4.2). However, as the temperature was raised from 25 
o
C to 85 
o
C, most of 
the signals broadened and the AB coupled resonances coalesced, most likely due to 
restricted rotation of Fmoc-alanine on the N-terminus of dipeptide adduct 75, meaning 







H NMR spectrum of adduct 75 in DMSOd6 at variable temperature at 500 
MHz (region  3.5 to 6.0 ppm expanded) 
 
4.2 C-terminus extension 
In a previous study, the ring opening of N-acylated morpholinone templates was 
achieved using Weinreb’s modified dimethylaluminium amide method, relatively harsh 
condition found necessary due to the relative unreactivity of the lactone to nucleophilic 
ring opening.
1
 The drawbacks of this protocol are that the intermediate 
dialkylaluminium amide is hydrolytically unstable and the reagent used 
trimethylaluminium is very sensitive to air and moisture, requiring rigorously 




Initial attempts at ring opening of the N-acylated morpholinone template using simple 
carboxyl-protected amino acids was unsuccessful.
1
 However, by applying ultra-high 
pressure (19 kbar) to the reaction over 48 hours, the nucleophilic ring opening was 
found to occur, although it should be noted that such equipment is not generally 
available.
7
 The morpholinone side chain appeared to be a source of steric hindrance 
blocking the coupling at C-terminus to occur. This was demonstrated by failure of the 




It was proposed that the use of the more electrophilic thiomorpholinone template
3
 
would allow the aminolysis of the template with a similar procedure using carboxyl-
protected amino acids without subjecting the system to ultra-high pressure.
9
 Initial 
results in this area had been disclosed by the Harwood group in 2012, when they 
reporting the ring opening of N-acylated of 3,5-disubstituted thiomorpholinones with 
carboxyl-protected amino acids.
9
 With less steric hindrance at the C-3 position of 75, 
only possessing hydrogen at a side chain, we presumed the C-terminus extension on the 
thiolactone function would work by adapting the similar approach.  
Thus, the carboxyl protected amino acid was prepared by adding alanine tBu ester 
hydrochloride to a suspension of sodium carbonate in a water – diethyl ether (1 : 1) 
(Scheme 4.4). After 1 hour, the resulting solution was extracted into diethyl ether, dried, 
filtered and concentrated to give alanine tBu ester 76 as a colourless oil in 72 % yield. 
The preparation of 76 was supported from mass spectrometric analysis showing a 







Scheme 4.4 (i) NaCO3, deionized water – diethyl ether (1 : 1), room temperature, 1 
hour  
The nucleophilic ring opening of N-acylated thiomorpholinone 75 was then attempted 
with alanine tBu ester 76 (Scheme 4.5). The reaction was stirred vigorously in dry 
dichloromethane at room temperature overnight and the crude product was purified 
over silica, eluting with diethyl ether – dichloromethane (6 : 1), to give tripeptide 
precursor 77 as a yellow oil in 28 % yield. 
 
Scheme 4.5 (i) alanine tBu ester 76, dry dichloromethane, room temperature, overnight, 
N2 atmosphere  
The success of C-terminus peptide extension via thiolactone ring opening was verified 
by the observation of two doublets resonating at δ 1.44 ppm (J = 6.5 Hz) and δ 1.39 
ppm (J = 6.0 Hz), indicating the presence of two alanine methyl side chains (Figure 
4.3). Furthermore, two broad multiplet signals appearing at δ 4.39 – 4.29 ppm and δ 
4.27 – 4.17 ppm could be assigned to the CH protons of the two alanine residues. 
Although unresolved in the 
1
H NMR spectrum, both broad signals were shown to 








analysis. In the 
1
H NMR spectrum, an ABX system was observed at δ 5.79 ppm (J = 
10.0 Hz, J’ = 6.5 Hz) and δ 3.12 – 3.00 ppm as a double doublet and multiplet 
integrating to one proton and two protons respectively. A pair of AB coupled 
resonances was also detected at δ 3.93 ppm (J = 16.5 Hz) and δ 3.61 ppm (J = 16.5 Hz). 
Further analysis by mass spectrometry confirmed that the desired N-Fmoc ala-gly-ala 
C-t-butyl tripeptide 77 had been obtained with a molecular ion being observed at 
632.2789 [MH
+






H NMR spectrum of a tripeptide precursor 77 in CDCl3 
Unfortunately, the tripeptide derivative ala-gly-ala 77 with a simple benzylamine 
protection, rather than a 4-methoxybenzylamine auxiliary means that mild removal of 
the benzyl substituent is not possible, although global removal of the Fmoc and tert-




conditions using lithium in liquid ammonia as exemplified in the synthesis of the L-ala-
L(D)-ala-L-ala tripeptides based on the morpholinone template protocol.
1
 The presence 
of the substituent methoxy group on the phenyl ring would allow deprotection of 77 
under milder conditions using TFA and piperidine.
9
 Attempts at incorporating the 
methoxy group into the glycine thiomorpholinone system were carried out concurrently 
to this work are described in Chapter 2. Despite this, the short study carried out here 
demonstrates that the thiomorpholinone template is indeed a viable means of carrying 
out C-terminus peptide extension under mild conditions without causing epimerization 
at the C-terminus residue due to oxazolone formation. This finding also suggests that 
the synthesis of a longer peptide could be applied in a convergent strategy using the 
thiomorpholinone template methodology rather than stepwise linear synthesis, where 
the overall yield reduces with each reaction step. This approach would allow two 
peptide fragments to be combined using N- and C- terminus of thiomorpholinone 
templates to generate a larger peptide derivative.  
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Conclusions and future work  
 
In conclusion, a synthetic route to access C-3 unsubstituted thiomorpholinone template 
32 has been developed for the first time, comprising seven steps beginning with 
commercially available 2-amino-2-phenylethanol. The key step involves the ring 
opening of Boc-phenylmorpholinone 36 to give methyl ester 40. The sulfur introduction 
was accomplished through a Mitsunobu reaction to yield thioacetate methyl ester 41, 
which was then hydrolysed to provide thioacid 42. Cyclisation of the thioacid 42 was 
achieved under mild conditions using DCC in the presence of DMAP, to give 43, and 
subsequent deprotection afforded the desired C-3 unsubstituted thiomorpholinone 32.  
Attempts at improvement of this developed pathway have been carried out. The 
improved synthetic route was reduced to six steps by preparing methyl ester 44 in a one 
pot strategy via N-alkylation of 2-amino-2-phenylethanol with methyl bromoacetate 
(Scheme 5.1). This shorthened pathway allows more straightforward access to the 
desired thiomorpholinone template 32 without having to prepare morpholinone 34. 
A plan for the incorporation of a 4-methoxy group on the thiomorpholinone system was 
initiated with the successful preparation of Boc-hydroxy methyl ester 52 by adapting 
the shorter procedure for synthesis of 32. For the continuation of this work in the future, 
it is recommended to adopt this approach as it most probably would require four more 
steps to access 5-(4-methoxyphenyl)thiomorpholinone.  
With the C-3 unsubstituted thiomorpholinone template available, the preparation of a 
tripeptide containing glycine was exemplified by preparing a tripeptide derivative ala-




epimerization due to oxazolone formation during the C-terminus extension.  This study 
demonstrates that thiomorpholinones can act as N-acylated C-terminus activated amino 
acids. It is recommended to carry out the convergent synthesis of a longer peptide in the 
future to demonstrate its utility as an alternative to the standard linear repetitive N-
terminus extension strategy most commonly used.  
Scheme 5.1 Improved synthetic route to access glycine-derived thiomorpholinone (i) 
Methyl bromoacetate, Et3N, dry THF, 0 
o
C to room temperature, 24 hours (ii) Di-tert-
butyl dicarbonate, Et3N, EtOAc, room temperature, 6 hours (iii) DIAD, 
triphenylphosphine, dry THF, 0 
o
C, 30 minutes, N2 atmosphere, thioacetic acid, dry 
THF, 0 
o
C, 1 hour, room temperature, 24 hours, N2 atmosphere (iv) LiOH, water, i-
PrOH, room temperature, overnight (v) DCC, CH2Cl2, 0 
o
C, 15 minutes, DMAP, room 
temperature, overnight (vi) TFA, CH2Cl2, 0 
o








All chemicals and reagents were purchased from Sigma-Aldrich, Alfa Aesar and Tokyo 
Chemical Industries. Acetonitrile was dried over 4 Å molecular sieves and 
tetrahydrofuran was dried by distillation from sodium benzophenone ketyl.  
All 
1
H NMR spectra were recorded either at Bruker Avance DPX400 spectrometer or at 
500 MHz on a Bruker AVIII500 spectrometer. 
13
C NMR spectra were recorded at 100 
MHz on the first spectrometers. NMR solvents used were chloroform-d, dimethyl 
sulfoxide-d6 and methanol-d4. Spectra are reported on the δ scale referenced to 
tetramethylsilane (TMS). The abbreviations s, d, t, m, dd, br, app are used to denote 
singlet, doublet, triplet, multiplet, double doublet, broad and apparent respectively.  
Infrared spectra were recorded on a Perkin-Elmer spectrometer in the frequency range 
4000 - 400 cm
-1
. Mass spectrometry (m/z) analysis and accurate mass measurements 
(HRMS) were determined on a Thermo Scientific LTQ-Orbitrap-XL mass spectrometer 
using electrospray ionisation (ESI) technique. Specific rotations were determined on a 
Perkin-Elmer polarimeter at the sodium D line (589 nm). Melting points were 
determined with a Buchi melting point apparatus. Thin layer chromatography (TLC) 
analyses were performed using 0.25 mm thick silica gel 60 F254 plates in the appropriate 
solvent system. Compound visualization was carried out using a UV source at 254 nm 
and staining with potassium permanganate solution. Column chromatography was 














(S)-2-phenylglycinol (4.0 g, 29.2 mmol, 1.0 equiv) and N,N-diisopropylethylamine 
(12.5 mL, 73.0 mmol, 2.5 equiv) were dissolved in dry acetonitrile (100 mL) under an 
atmosphere of nitrogen at room temperature. Phenyl bromoacetate (6.9 g, 32.1 mmol, 
1.1 equiv) in dry acetonitrile (25 mL) was added dropwise over 10 minutes and the 
mixture was stirred for 24 h at room temperature, then concentrated under reduced 
pressure to give the crude product. Purification by chromatography on Florisil
®
, with a 
2 cm layer of K2CO3 on top of the column, eluting with petroleum ether – diethyl ether 
(1 : 2) followed by acetone afforded morpholin-2-one 34 (3.6 g, 70 % yield) as a pale 
yellow oil.  




H NMR (400 MHz, CDCl3) δ 7.42 
- 7.34 (5H, m, Ph), 4.42 (1H, dd, J = 11.0 Hz, J’ = 4.5 Hz, CH2O), 4.31 (1H, app t, J = 
11.0 Hz, PhCH), 4.20 (1H, dd, J = 11.0 Hz, J’ = 4.0 Hz, CH2O), 3.98 (1H, d, J = 18.0 
Hz, CH2NH), 3.86 (1H, d, J = 18.0 Hz, CH2NH), 2.18 (1H, s, NH). 
13
C NMR (100 
MHz, CDCl3): δ 155.8, 129.6, 128.8, 128.0, 127.4, 66.8, 64.2, 52.0. HRMS calcd for 











(S)-5-phenylmorpholin-2-one 34 (3.53 g, 19.9 mmol, 1.0 equiv), di-tert-butyl 
dicarbonate (4.78 g, 21.9 mmol, 1.1 equiv) and triethylamine (2.78 mL, 19.9 mmol, 1.0 
equiv) were dissolved in diethyl ether (50 mL) at room temperature and the resulting 
mixture was stirred for 6 hours. The reaction mixture was then concentrated under 
reduced pressure, diluted with diethyl ether (25 mL), washed with 5 % aqueous HCl (15 
mL) and saturated aqueous NaHCO3 (15 mL), dried over anhydrous MgSO4, filtered 
and concentrated in vacuo to give the crude product as a yellow oil. Purification by 
chromatography over silica, eluting with diethyl ether, yielded 36 (3.2 g, 58 %) as a 




 87 – 88 
o
C).  





(500 MHz, DMSO d6, 85 
o
C) δ 7.37 - 7.26 (5H, m, Ph), 5.05 (1H, app t, J = 4.0 Hz, 
PhCH), 4.64 (1H, dd, J = 8.0 Hz, J’ = 4.0 Hz, CH2O), 4.47 (1H, app. dd, J = 12.0 Hz, J’ 
= 4.0 Hz, CH2O), 4.43 (1H, d, J = 12.0 Hz, CH2N), 4.31 (1H, d, J = 12.0 Hz, CH2N), 
1.27 (9H, s, t-butyl).
 13
C NMR (500 MHz, DMSO d6): 168.8, 154.0, 139.8, 129.1, 













To a solution of 34 (2.8 g, 15.8 mmol, 1.0 equiv) in dichloromethane (50 mL) was 
added K2CO3 (10.9 g, 79.0 mmol, 5 equiv) and the solution was stirred for 10 minutes. 
Fmoc-Cl (4.9 g, 18.9 mmol, 1.2 equiv) was then added and the mixture left overnight. 
The resulting mixture was quenched with water (20 mL), extracted with 
dichloromethane (50 mL x 3), dried over anhydrous MgSO4, filtered and concentrated 
in vacuo to give the crude product that was purified over silica, eluting with 
approximately 0.5 L of chloroform then acetone to afford 37 as pale yellow oil (4.7 g, 
74 %).  




H NMR (500 MHz, 
DMSO d6, 85 
o
C) δ 7.82 (2H, d, J = 4.0 Hz, Ph), 7.65 (2H, d, J = 4.0 Hz, Ph), 7.39 – 
7.18 (9H, bm, Ph), 5.05 (1H, app bt, J = 4.0 Hz, PhCH), 4.65 (1H, dd, J = 12.0 Hz, J’ = 
4.0 Hz, PhCHCH2), 4.47 (1H, dd, J = 12.0 Hz, J’ = 4.0 Hz, PhCHCH2), 4.42 (1H, d, J = 
16.0 Hz, CH2CO), 4.34 (1H, app t, J = 4.0 Hz, CHCH2O), 4.24 (1H, d, J = 16.0 Hz, 
CH2CO), 4.17 (2H, bs, CHCH2O). 
13
C NMR (100 MHz, DMSO d6): 168.7, 154.3, 
145.9, 144.0, 141.2, 129.2, 128.1, 127.6, 126.4, 125.7, 125.4, 120.6, 79.7, 70.3, 64.2, 











To a solution of Et3N (6.99 g, 69.1 mmol, 6.0 equiv) in MeOH (50 mL) was added a 
solution of 36 (3.19 g, 11.5 mmol, 1.0 equiv) in MeOH (5 mL). The reaction mixture 
was stirred for 24 h and then concentrated in vacuo to give a crude product that was 
purified over silica eluting with petroleum ether – diethyl ether (1 : 2) to afford ester 40 
(2.72 g, 76 %) as a colourless oil.  




H NMR (400 MHz, DMSO d6) δ 
7.40 - 7.24 (5H, m, Ph), 5.22 (1H, app t, J = 8.0 Hz, PhCH), 4.87 – 4.81 (2H, m, 
CH2OH), 3.91 – 3.84 (2H, m, CH2N), 3.58 (3H, s, OCH3), 1.35 (9H, bs, t-butyl). 
13
C 
NMR (100 MHz, DMSO d6): δ 170.9, 154.3, 138.6, 128.1, 79.4, 60.6, 51.6, 45.5, 27.9. 
HRMS calcd for C16H24NO5: 310.1654 and C16H23NO5Na: 332.1474, found 310.1649 
(MH
+













Synthesis of methyl (S)-N-(2-(acetylthio)-1-phenylethyl)-N-(tert-
butoxycarbonyl)glycinate (41).  
 
DIAD (3.49 g, 17.3 mmol, 2.0 equiv) was added dropwise to a solution of 
triphenylphosphine (4.53 g, 17.3 mmol, 2.0 equiv) in dry tetrahydrofuran (100 
mL) under an atmosphere of nitrogen at 0 
o
C for 30 minutes. A milky white 
mixture resulted. A solution of 40 (2.67 g, 8.64 mmol, 1.0 equiv) and thiolacetic 
acid (1.32 g, 17.3 mmol, 2.0 equiv) in dry tetrahydrofuran (25 mL) was then 
added dropwise and the stirring was continued for 1 h at 0 
o
C and then left 
overnight at room temperature resulting in a clear yellow solution. Ether (25 mL) 
was added and the solution was washed with water (50 mL), dried over Na2SO4, 
filtered and concentrated in vacuo. The crude product was purified by column 
chromatography, eluting with hexane – ethyl acetate (7 : 1) to give 41 (1.28 g, 40 
%) as a yellow oil.  




H NMR (400 MHz, CDCl3) δ 7.33 
- 7.30 (5H, m, Ph), 5.54 (1H, t, J = 8.0 Hz, PhCH), 3.79 (1H, d, J = 16.0 Hz, 
CH2N), 3.61 (3H, s, OCH3), 3.56 (1H, app d, J = 16.0 Hz, CH2N), 3.44 – 3.38 
(2H, bm, CH2S), 2.33 (3H, s, CH3COS), 1.44 (9H, bs, t-butyl).  
13
C NMR (500 
MHz, CDCl3): 195.4, 170.7, 154.9, 152.9, 129.0, 128.1, 126.2, 81.7, 72.4, 70.6, 
69.8, 28.4, 25.3, 21.9. HRMS calcd for C18H26NO5S: 368.1532 and 
C18H25NO5SNa: 390.1351, found 368.1524 [MH
+










phenylethyl)glycine (42).  
 
To a solution of 41 (1.16 g, 3.16 mmol, 1.0 equiv) in i-PrOH (80 mL) was added 
dropwise a solution of lithium hydroxide (0.53 g, 12.6 mmol, 4.0 equiv) in water 
(50 mL) at room temperature under an atmosphere of nitrogen. The reaction 
mixture was then stirred at room temperature overnight. Water (50 mL) was then 
added and the pH of the mixture was adjusted to pH 5 with 1 M HCl. The 
aqueous mixture was extracted with ethyl acetate (3 x 100 mL) and the combined 
organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. 
Purification by column chromatography, eluting with hexane - ethyl acetate - 
formic acid (4 : 1 : 0.01) afforded 42 (0.68 g, 69 %) as a yellow oil.  




H NMR (400 MHz, DMSO 
d6) δ 7.35 - 7.27 (5H, m, Ph), 5.28 (1H, t, J = 8.0 Hz, PhCH), 3.63 (1H, d, J = 
17.5 Hz, CH2N), 3.55 (1H, d, J = 17.5 Hz, CH2N), 3.09 (2H, bm, CH2SH), 1.37 
(9H, bs, t-butyl). 
13
C NMR (500 MHz, CDCl3): 173.4, 154.6, 137.7, 129.0, 128.4, 
127.7, 81.3, 61.1, 45.3, 29.8, 28.4. HRMS calcd for C15H22NO4S: 312.1270 and 
C15H21NO4SNa: 334.1089, found 312.1264 (MH
+











Synthesis of tert-butyl (S)-2-oxo-5-phenylthiomorpholine-4-carboxylate (43).  
 
DCC (0.45 g, 2.19 mmol, 1.1 equiv) was added to a solution of 42 (0.62 g, 1.99 mmol, 
1.0 equiv) in dichloromethane (50 mL) and the reaction mixture was stirred at 0 
o
C for 
15 minutes. DMAP (0.27 g, 2.19 mmol, 1.1 equiv) was then added and the mixture was 
left overnight at room temperature. Dicyclohexylurea, formed as a white precipitate, 
was removed by filtration, the filtrate was concentrated under reduced pressure and the 
residue purified over silica, eluting with hexane – ethyl acetate (4 : 1) giving 43 (0.32 g, 
55 %) as pale yellow oil.  




H NMR (500 MHz, DMSO d6, 85 
o
C) δ 7.35 (5H, m, Ph), 5.14 (1H, app t, J = 7.0 Hz, PhCH), 4.52 (1H, d, J = 16.0 Hz, 
CH2N), 4.33 (1H, d, J = 16.0 Hz, CH2N), 3.57 (2H, br d, J = 7.0 Hz, CH2S), 1.26 (9H, 
s, t-butyl).
 13
C NMR (500 MHz, DMSO d6): 200.2, 154.7, 142.8, 129.0, 128.1, 127.8, 





-38.2 (c 0.3, CHCl3). 
 
Synthesis of (S)-5-phenylthiomorpholin-2-one (32) 
 
To a solution of 43 (0.3 g, 1.02 mmol, 1.0 equiv) in dichloromethane (5 mL) was added 
TFA (5 mL) at 0 
o
C and the mixture stirred at room temperature for 2 hours. The 




mixture was evaporated in vacuo, redissolved in dichloromethane (5 mL), washed with 
NaHCO3 (2 mL) and brine (2 mL), dried over anhydrous MgSO4 and concentrated 
under reduced pressure to give 32 as a yellow oil (0.16 g, 81 %).  




H NMR (400 MHz, CDCl3) δ 7.43 – 
7.20 (5H, m, Ph), 4.24 (1H, dd, J = 11.0 Hz, J’ = 3.5 Hz, PhCH), 3.86 (1H, d, J = 
17.5 Hz, CH2CO), 3.81 (1H, d, J = 17.5 Hz, CH2CO), 3.48 (1H, t, J = 12.0 Hz, 
CH2S), 3.19 (1H, dd, J = 12.0 Hz, J’ = 3.5 Hz, CH2S), 2.16 (1H, bs, NH). 
13
C 
NMR (100 MHz, CDCl3): δ 198.2, 141.7, 129.0, 128.3, 126.3, 58.5, 58.3, 36.8. 





(c 0.5, CHCl3). 
 




To a solution of (S)-2-phenylglycinol (5 g, 36.4 mmol, 1.0 equiv) in dry 
tetrahydrofuran (100 mL) was added triethylamine (6.1 mL, 43.7 mmol, 1.2 
equiv) at 0 
o
C. A solution of methyl bromoacetate (6.1 g, 40.0 mmol, 1.1 equiv) 
in dry tetrahydrofuran (40 mL) was added dropwise and the reaction mixture was 
left to warm to room temperature over 24 h. The mixture was then diluted with 
saturated NH4Cl solution (30 mL), extracted with diethyl ether (3 x 100 mL), 
dried over anhydrous MgSO4, filtered and concentrated in vacuo to give the 
crude product. The crude product was purified by column chromatography over 
silica eluting with hexane – ethyl acetate (1 : 1) to give 44 as a pale yellow oil 








H NMR (400 MHz, CDCl3) δ 7.37 – 
7.29 (5H, m, Ph), 3.80 (1H, dd, J = 8.5 Hz, J’ = 4.5 Hz, PhCH), 3.74 (1H, dd, J = 
11.0 Hz, J’ = 4.5 Hz, CH2OH), 3.70 (3H, s, OCH3), 3.61 (1H, dd, J = 11.0 Hz, J’ 
= 8.5 Hz, CH2OH), 3.40 (1H, d, J = 17.5 Hz, HNCH2), 3.30 (1H, d, J = 17.5 Hz, 
HNCH2), 1.92 (1H, bs, NH). 
13
C NMR (100 MHz, CDCl3): 172.7, 139.5, 128.8, 





Synthesis of methyl (S)-(2-(acetylthio)-1-phenylethyl)glycinate (45) 
 
To a solution of triphenylphosphine (14.2 g, 54.1 mmol, 2.0 equiv) in dry 
tetrahydrofuran (250 mL) was added DIAD (10.9 g, 54.1 mmol, 2.0 equiv) under 
an atmosphere of nitrogen at 0 
o
C over 30 minutes. A milky white mixture 
resulted. A solution of 44 (5.65 g, 27.0 mmol, 1.0 equiv) and thiolacetic acid 
(4.11 g, 54.1 mmol, 2.0 equiv) in dry tetrahydrofuran (50 mL) was then added 
dropwise, stirring  was continued for 1 hour at 0 
o
C and then the mixture was left 
overnight at room temperature. A clear yellow solution was obtained. Diethyl 
ether (50 mL) was then added and the mixture was washed with water (100 mL), 
dried over anhydrous Na2SO4, filtered and concentrated in vacuo to give the 
crude product. Purification of the crude product over silica, eluting with hexane – 









NMR (400 MHz, CDCl3) δ 7.41 - 7.30 (5H, m, Ph), 5.18 (1H, t, J = 7.0 Hz, 
PhCH), 3.91 (1H, d, J = 17.0 Hz, HNCH2), 3.67 (3H, s, OCH3), 3.37 (1H, d, J = 
17.0 Hz, HNCH2), 3.10 (2H, m, CH2S), 2.48 (3H, s, CH3COS).  
13
C NMR (400 
MHz, CDCl3): 194.2, 170.1, 137.5, 129.1, 128.8, 127.2, 64.3, 52.2, 46.2, 44.1, 
26.4. HRMS calcd for C13H18NO3S: 268.1007 and C13H17NO3SNa: 290.0827, 
found 268.1002 (MH
+




Synthesis of methyl (S)-N-(tert-butoxycarbonyl)-N-(2-((methylsulfonyl)oxy)-
1-phenylethyl)glycinate (46) 
 
To a solution of 40 (1.0 g, 3.24 mmol, 1.0 equiv) and N,N-diisopropylethylamine 
(0.84 g, 6.48 mmol, 2.0 equiv) in dichloromethane (15 mL) was added dropwise 
methanesulfonyl chloride (0.45 g, 3.89 mmol, 1.2 equiv) at 0 
o
C. The reaction 
mixture was stirred for 1 hour at 0 
o
C and stirring then continued for 2 hours at 
room temperature. The resulting mixture was diluted with dichloromethane (15 
mL), washed sequentially with saturated NH4Cl (15 mL) and brine (15 mL), 
dried over anhydrous Na2SO4, filtered and concentrated in vacuo to give 46 (0.42 
g, 34 %) as a yellow oil.  
1
H NMR (400 MHz, CDCl3) δ 7.42 - 7.32 (5H, m, Ph), 5.06 (1H, t, J = 8.5 Hz, 
PhCH), 4.72 (1H, t, J = 8.5 Hz, OCH2), 4.30 (1H, d, J = 18.0 Hz, NCH2), 4.15 




18.0 Hz, NCH2), 1.59 (9H, s, tBu).  
13
C NMR (400 MHz, CDCl3): 167.6, 154.4, 
139.3, 129.5, 128.2, 127.2, 79.5, 70.3, 68.2, 59.9, 50.7, 43.0, 28.1. HRMS calcd 
for C17H25NO7SNa: 410.1249, found 410.1244 (MNa
+
). 
Synthesis of (S)-N-(tert-Butyloxycarbonyl)-4-hydroxyphenyl-glycine (48)
[3] 
 
A solution of di-tert-butyl dicarbonate (12.9 g, 59.2 mmol, 1.1 equiv) in dioxane (54 
mL) was added to a solution of S-(4-hydroxyphenyl)-glycine (9.0 g, 53.8 mmol, 1.0 
equiv) and NaOH (2.15 g, 53.8 mmol, 1.0 equiv) in H2O - dioxane 2 : 1 (162 mL). The 
reaction mixture was stirred for 4 hours at room temperature, the dioxane was then 
evaporated and the aqueous phase was acidified to pH 3 with KHSO4. This was 
extracted with ethyl acetate (3 x 150 mL), the combined organic phases dried over 
anhydrous MgSO4, filtered and concentrated to give product 48 as white solid (12.3 g, 
86 %).  mp 199 - 201 
o
C.  




H NMR (400 MHz, DMSO d6) δ 
9.48 (1H, bs, OH), 7.39 (1H, J = 8.0 Hz, NHBoc), 7.18 (2H, d, J = 8.5 Hz, Ph), 6.72 
(2H, d, J = 8.5 Hz, Ph), 4.96 (1H, d, J = 8.0 Hz, PhCH), 1.38 (9H, s, tBu). 
13
C NMR 
(100 MHz, DMSO d6): δ 172.7, 157.0, 155.1, 128.9, 127.5, 115.0, 78.2, 58.4, 28.2. 















K2CO3 (24.9 g, 180 mmol, 4.0 equiv) and MeI (19.2 g, 135 mmol, 3.0 equiv) were 
added to a solution of 48 (12.0 g, 45.0 mmol, 1.0 equiv) in acetone (200 mL). The 
reaction mixture was heated at reflux for 16 hours, cooled and then filtered through a 
short pad of Celite
®
. The solution was washed with brine (100 mL), the organic phase 
dried over anhydrous MgSO4, filtered and concentrated under reduced pressure to give 
the crude product that was purified by column chromatography over silica, eluting with 
petroleum ether – diethyl ether (2 : 1), to afford 49 as a white solid (5.50 g, 41 %). mp 
73 - 75 
o
C.  




H NMR (400 MHz, CDCl3) δ 7.27 
(2H, d, J = 9.0 Hz, Ph), 6.87 (2H, d, J = 9.0 Hz, Ph), 5.49 (1H, bd, J = 6.0 Hz, NH), 
5.25 (1H, d, J = 7.0 Hz, PhCH), 3.79 (3H, s, OCH3), 3.71 (3H, s, OCH3), 1.43 (9H, s, 
tBu). 
13
C NMR (100 MHz, CDCl3): δ 171.9, 159.7, 154.8, 129.0, 128.4, 114.3, 80.1, 
57.0, 55.3, 52.6, 28.3. HRMS calcd for C15H22NO5: 296.1498 and C15H21NO5Na: 
318.1317, found 296.1492 (MH
+















Method 1: To a suspension of lithium aluminium hydride (1.68 g, 44.1 mmol, 4.0 
equiv) in tetrahydrofuran (150 mL) was added a solution of 49 (3.25 g, 11.0 mmol, 1.0 
equiv) in tetrahydrofuran (50 mL). The mixture was stirred for 30 minutes. Ethyl 
acetate (60 mL) and 10 % aqueous KOH (w/w) (50 mL) were slowly added to the 
reaction and the mixture was left for 1 hour. The organic solvent was dried, redissolved 
in ethyl acetate (100 mL) and separated from aqueous layer. The resulting mixture was 
then dried over anhydrous MgSO4, filtered and concentrated under reduced pressure to 
give 50 as white solid (2.54 g, 65 %).   
Method 2: LiCl (2.05 g, 48.5 mmol, 2.6 equiv) was added to a suspension of NaBH4 
(1.83 g, 48.5 mmol, 2.6 equiv) in ethanol (69 mL) at 0 
o
C under an atmosphere of 
nitrogen and the mixture stirred for 10 minutes. A solution of 49 (5.50 g, 18.6 mmol, 
1.0 equiv) in tetrahydrofuran (69 mL) was subsequently added and the reaction left for 
3 hours at room temperature. The mixture was quenched with saturated NH4Cl solution 
(30 mL), water (100 mL) and extracted with ethyl acetate (3 x 150 mL). The organic 
extracts were combined and washed with brine (100 mL), dried over anhydrous 
Na2SO4, filtered and concentrated to give the crude product. Purification by column 
chromatography on silica gel, eluting with hexane – ethyl acetate (4 : 1), afforded 50 as 
a white solid (4.01 g, 80.5 %). mp 140 – 142 
o
C.  




H NMR (400 MHz, CDCl3) δ 7.22 
(2H, d, J = 8.5 Hz, Ph), 6.89 (2H, d, J = 8.5 Hz, Ph), 5.12 (1H, bs, NH), 4.73 (1H, bs, 






C NMR (100 MHz, CDCl3): δ 159.1, 156.2, 131.5, 127.7, 114.2, 80.0, 67.0, 
56.4, 55.3, 28.4. HRMS calcd for C14H22NO4: 268.1549 and C14H21NO4Na: 290.1368, 
found 268.1542 (MH
+




Synthesis of (S)-2-amino-2-(4-methoxyphenyl)ethan-1-ol (47)
[4] 
 
To a solution of 50 (0.55 g, 2.08 mmol, 1.0 equiv) in dichloromethane (6 mL) was 
added TFA (6 mL) at 0 
o
C and the  mixture allowed to stir at room temperature until the 
starting material was consumed, monitoring by TLC. The resulting mixture was 
evaporated in vacuo, redissolved in dichloromethane (15 mL), washed with saturated 
NaHCO3 (10 mL) and brine (10 mL), dried over anhydrous MgSO4, filtered and 
concentrated to give 47 as a yellow oil (295 mg, 85 %).  




H NMR (400 MHz, CDCl3) δ 7.24 (2H, 
d, J = 8.5 Hz, Ph), 6.89 (2H, d, J = 8.5 Hz, Ph), 4.06 (1H, bs, PhCH), 3.80 (3H, s, 
OCH3), 3.74 (1H, bs, CH2OH), 3.60 (1H, t, J = 9.5 Hz, CH2OH), 1.85 (3H, bs, NH2 and 
OH). 
13
C NMR (100 MHz, CDCl3): δ 159.4, 131.1, 128.8, 114.0, 63.6, 55.8, 55.1. 
HRMS calcd for C9H14NO2: 168.1024, found 168.1019 (MH
+
). 







Triethylamine (0.28 mL, 1.99 mmol, 1.2 equiv) was added to a solution of 47 (0.28 g, 
1.66 mmol, 1.0 equiv) in dry tetrahydrofuran (7 mL) at 0 
o
C. A solution of methyl 
bromoacetate (0.28 g, 1.82 mmol, 1.1 equiv) in tetrahydrofuran (2 mL) was then added 
dropwise and the reaction mixture was allowed to warm to room temperature over 24 
hours. The resulting mixture was diluted with saturated NH4Cl solution (2 mL), 
extracted with diethyl ether (3 x 10 mL), dried over anhydrous MgSO4, filtered and 
concentrated to give the crude product as a yellow oil. This was purified by column 
chromatography over silica, eluting with hexane – ethyl acetate (1 : 1), followed by 
ethyl acetate to afford 51 as a yellow oil (60.3 mg, 15 %).  
IR (ATR): max 3324, 2953, 1739 cm
-1
.   
1
H NMR (400 MHz, CDCl3) δ 7.16 (2H, d, J = 
7.5 Hz, Ph), 6.81 (2H, d, J = 7.5 Hz, Ph), 3.73 (3H, s, OMePh), 3.68 (1H, dd, J = 8.5 
Hz, J’ = 4.0 Hz, PhCH), 3.65 – 3.62 (1H, bm, CH2OH), 3.62 (3H, s, OCH3), 3.52 (1H, 
t, J = 9.0 Hz, CH2OH), 3.31 (1H, d, J = 17.5 Hz, HNCH2), 3.21 (1H, d, J = 17.5 Hz, 
HNCH2), 2.20 (1H, bs, NH). 
13
C NMR (100 MHz, CDCl3): 173.1, 159.3, 131.6, 128.5, 
114.1, 67.0, 63.5, 55.3, 51.8, 48.3. HRMS calcd for C12H18NO4: 240.1236 and 
C12H17NO4Na: 262.1055, found 240.1230 (MH
+
) and 262.1050 (MNa
+
). 




To a solution of 2-bromoacetophenone (5.0 g, 25.1 mmol, 1.0 equiv) in acetone (60 




equiv). Benzyl thiol (2.98 mL, 25.4 mmol, 1.01 equiv) was then added dropwise and a 
white precipitate was immediately formed. The reaction mixture was left for 1 hour and 
concentrated in vacuo to give the crude product. Purification of the crude product over a 
short silica column, eluting with hexane – ethyl acetate (4 : 1), afforded 56 as a white 




 86 - 88 
o
C) 
IR (ATR): max 3060, 3028, 1670 cm
-1
.   
1
H NMR (400 MHz, CDCl3) δ 7.93 (2H, d, J = 
7.0 Hz, Ph), 7.58 (1H, t, J = 7.5 Hz, Ph), 7.46 (2H, t, J = 7.5 Hz, Ph), 7.37 – 7.25 (5H, 
m, Ph), 3.76 (2H, s, CH2CO), 3.68 (2H, s, SCH2Ph). 
13
C NMR (100 MHz, CDCl3): 
192.1, 138.6, 134.4, 132.5, 128.7, 128.5, 128.2, 43.2. 37.6. HRMS calcd for C15H15OS: 
243.0844, found 243.0838 (MH
+
).  




To a solution of 56 (1.0 g, 4.13 mmol, 1.0 equiv) in methanol (35 mL) was added 
ammonium acetate (3.18 g, 41.3 mmol, 10.0 equiv) and sodium cyanoborohydride (0.18 
g, 2.89 mmol, 0.7 equiv) and the reaction mixture heated to reflux for 24 hours. The 
mixture was allowed to cool and washed with 5 % HCl (20 mL), 5 M NaOH (20 mL), 
extracted with ethyl acetate (3 x 50 mL), dried over anhydrous MgSO4, filtered and 
concentrated in vacuo to give the crude product. Purification of the crude product over 





IR (ATR): max 3314, 3064, 3027, 2922, 1559 cm
-1
.   
1
H NMR (400 MHz, CDCl3) δ 
7.33 – 7.21 (10H, m, Ph), 4.90 (2H, bs, NH2), 4.08 (1H, dd, J = 8.0 Hz, J’ = 6.0 Hz, 
PhCH), 3.66 (1H, d, J = 13.5 Hz, SCH2Ph), 3.61 (1H, d, J = 13.5 Hz, SCH2Ph), 2.86 – 
2.76 (2H, m, CH2). 
13
C NMR (100 MHz, CDCl3): 142.7, 138.1, 129.5, 128.9, 128.3, 




Synthesis of tert-butyl (S)-(2-(benzylthio)-1-phenylethyl)glycinate (60) 
 
To a solution of 59 (1.5 g, 5.49 mmol, 1.0 equiv) in dry tetrahydrofuran (28 mL) was 
added triethylamine (1.92 mL, 13.7 mmol, 2.5 equiv). The mixture was cooled to 0 
o
C 
and tert-butyl bromoacetate (2.68 g, 13.7 mmol, 2.5 equiv) was then added dropwise. 
The reaction mixture allowed to warm to room temperature and the stirring was 
continued for 24 hours. The resulting mixture was quenched with brine (15 mL), 
extracted with ethyl acetate (3 x 50 mL), dried over anhydrous MgSO4, filtered and 
concentrated in vacuo to give the crude product. Purification of the crude product over 
silica, eluting with hexane – ethyl acetate (4 : 1), afforded 60 as a pale yellow oil (0. 
617 g, 28 %).  
IR (ATR): max 3314, 3061, 3027, 2979, 2930, 1732, 1456, 1368, 1146 cm
-1
.   
1
H NMR 
(400 MHz, CDCl3) δ 7.33 – 7.21 (10H, m, Ph), 3.75 (1H, d, J = 13.5 Hz, SCH2Ph), 3.70 
(1H, d, J = 13.0 Hz, SCH2Ph), 3.72 (1H, m, PhCH), 3.19 (1H, d, J = 17.5 Hz, HNCH2), 




2.59 (1H, dd, J = 13.5 Hz, J’ = 9.5 Hz, CH2CHPh), 2.15 (1H, s, NH), 1.45 (9H, s, tBu). 
13
C NMR (100 MHz, CDCl3): 171.6, 138.2, 128.9, 128.6, 128.5, 127.7, 127.3, 127.0, 
81.1, 61.2, 49.3, 39.4, 36.0, 28.1. HRMS calcd for C21H28NO2S: 358.1841 and 
C21H27NO2SNa: 380.1660, found 358.1835 (MH
+




Synthesis of tert-butyl (S)-N-(((9H-fluoren-9-yl)methoxy)carbonyl)-N-(2-
(benzylthio)-1-phenylethyl)glycinate (61) 
 
To a solution of 60 (0.36 g, 1.01 mmol, 1.0 equiv) in dichloromethane (50 mL) was 
added K2CO3 (0.70 g, 5.06 mmol, 5.0 equiv) and the mixture was stirred for 10 
minutes. Fmoc-Cl (0.31 g, 1.21 mmol, 1.2 equiv) was then added and the stirring was 
continued overnight. The mixture was quenched with water (50 mL), extracted with 
dichloromethane (3 x 50 mL), dried over anhydrous MgSO4, filtered and concentrated 
in vacuo to give the crude product as pale yellow oil. Purification of the crude product 
over silica, eluting with hexane – ethyl acetate (7 : 1), afforded 61 as a pale yellow oil 
(0.41 g, 70 %).  
IR (ATR): max 3061, 2976, 1744, 1698, 1449, 1217, 1146 cm
-1
.   
1
H NMR (400 MHz, 
CDCl3) δ 7.75 (4H, d, J = 8.0 Hz, Ph), 7.60 (4H, d, J = 8.0 Hz, Ph), 7.45 – 7.13 (28H, 
m, Ph), 5.60 (1H, t, J = 7.5 Hz, CH), 5.05 (1H, t, J = 7.5 Hz, CH), 4.80 (1H, dd, J = 




(1H, m, PhCH), 4.45 – 4.39 (1H, m, SCH2), 4.28 – 4.22 (2H, bm, SCH2), 3.78 (2H, s, 
SCH2Ph), 3.68 – 3.54 (4H, m, NCH2), 3.38 (1H, s, SCH2Ph), 2.99 (2H, d, J = 7.5 Hz, 
OCH2), 2.78 (2H, d, J = 7.5 Hz, OCH2), 1.26 (9H, bs, tBu). 
13
C NMR (100 MHz, 
CDCl3): 168.4, 168.3, 156.4, 155.9, 144.1, 144.0, 141.6, 141.4, 138.2, 137.5, 129.1, 
129.0, 128.5, 128.2, 128.0, 127.8, 127.3, 127.2, 127.1, 125.3, 124.9, 124.8, 120.2, 
120.1, 81.6, 81.4, 68.0, 67.2, 58.1, 47.4, 45.9, 45.7, 36.5, 36.2, 32.5, 32.3, 27.9. HRMS 









A solution of 61 (0.2 g, 0.34 mmol, 1.0 equiv) in dichloromethane (2 mL) was cooled to 
0 
o
C, TFA (2 mL) was then added the mixture stirred for 30 minutes at 0 
o
C and then 
allowed to stir for 1 hour at room temperature. The resulting mixture was evaporated in 
vacuo and redissolved in dichloromethane (5 mL). The solution was then washed with 
saturated NaHCO3 (2 mL) and brine (2 mL), dried over anhydrous MgSO4, filtered and 
concentrated to afford 62 as a yellow oil (0.13 g, 70 %).  





(400 MHz, CDCl3) δ 7.75 (2H, d, J = 7.5 Hz, Ph), 7.59 (2H, d, J = 7.5 Hz, Ph), 7.41 – 




Hz, PhCH), 4.24 (1H, t, J = 6.5 Hz, CH), 3.87 (1H, d, J = 15.5 Hz, NCH2), 3.82 (1H, d, 
J = 15.5 Hz, NCH2), 3.72 (2H, s, SCH2Ph), 3.19 (1H, dd, J = 13.0 Hz, J’ = 5.0 Hz, 
SCH2), 3.00 (1H, dd, J = 13.0 Hz, J’ = 8.0 Hz, SCH2). 
13
C NMR (100 MHz, CDCl3): 
170.6, 156.8, 144.6, 143.4, 137.5, 136.9, 130.6, 129.3, 129.1, 128.9, 128.7, 128.4, 
127.4, 126.9, 126.6, 120.1, 60.9, 58.1, 45.8, 36.6, 34.4, 30.4. HRMS calcd for 
C32H29NO4SNa: 546.1715, found 546.1710 (MNa
+
). 




4-Methoxybromoacetophenone (8.4 g, 36.7 mmol, 1.0 equiv) was dissolved in acetone 
(90 mL) and the solution cooled in an ice-salt bath. Triethylamine (5.6 mL, 40.3 mmol, 
1.1 equiv) was added, followed by dropwise addition of benzyl mercaptan (4.4 mL, 
37.0 mmol, 1.01 equiv). The mixture was stirred for an hour and concentrated in vacuo 
to give the crude product. Purification of the crude product over a short silica column, 
eluting with hexane – ethyl acetate (4 : 1), afforded 64 as a white solid (7.7 g, 77 %). 
mp 65 – 67 
o
C.  




H NMR (400 MHz, CDCl3) δ 7.91 (2H, 
d, J = 9.0 Hz, Ph), 7.36 – 7.23 (5H, m, Ph), 6.93 (2H, d, J = 9.0 Hz, Ph), 3.87 (3H, s, 
OMe), 3.76 (2H, s, CH2CO), 3.63 (2H, s, SCH2Ph). 
13
C NMR (100 MHz, CDCl3): 
193.3, 163.7, 137.4, 131.1, 129.3, 128.4, 127.2, 113.8, 55.5, 36.2, 35.7 HRMS calcd for 














To a solution of 64 (6.6 g, 24.4 mmol, 1.0 equiv) in absolute ethanol (200 mL) was 
added pyridine (29.7 mL, 366.6 mmol, 15 equiv) and O-methyl hydroxylamine 
hydrochloride (6.12 g, 73.3 mmol, 3.0 equiv) and the mixture was heated to reflux for 2 
hours. After cooling to room temperature, the resulting mixture was concentrated in 
vacuo, dissolved in dichloromethane (100 mL), washed sequentially with 5 % HCl (70 
mL), brine (70 mL) and dried over anhydrous MgSO4. After filtration and removal of 
solvent in vacuo, purification of the crude product over silica, eluting with petrol ether – 
diethyl ether (2 : 1), afforded 67 as a colourless oil (5.12 g, 70 %) as a mixture of syn-
/ant-i (8/92) isomers.  




H NMR (400 MHz, CDCl3) 
δ 7.54 (2H, d, J = 9.0 Hz, Ph), 7.32 – 7.22 (5H, m, Ph), 6.87 (2H, d, J = 9.0 Hz, Ph), 
3.97 (3H, s, OMe), 3.82 (3H, s, OMe), 3.74 (2H, s, CH2C=N), 3.70 (2H, s, SCH2Ph). 
13
C NMR (100 MHz, CDCl3): 160.6, 154.1, 138.1, 130.1, 129.0, 128.4, 127.8, 127.1, 
113.9, 62.2, 55.3, 37.0, 24.9. HRMS calcd for C17H20NO2S: 302.1215, found 302.1209 
(MH
+











To a solution of 67 (3.40 g, 11.3 mmol, 1.0 equiv) in tetrahydrofuran (100 mL) was 
added 1 M BH3-THF (56.5 mL, 56.5 mmol, 5.0 equiv) at 0 
o
C. The mixture was then 
heated to reflux for 3.5 hours. After cooling to room temperature, water (70 mL) and 5 
M NaOH (70 mL) were added at 0 
o
C and the mixture was then stirred for 30 minutes at 
room temperature. The resulting mixture was acidified with 10 M HCl and the aqueous 
layer was extracted with ether (3 x 150 mL), basified with 28 % NH4OH (100 mL) and 
extracted with dichloromethane (3 x 100 mL). The organic extracts were combined, 
dried over anhydrous MgSO4, filtered and concentrated in vacuo to give the crude 
product that was purified over silica, eluting with ethyl acetate – methanol (4 : 1), to 
afford 65 as a yellow oil (2.68 g, 87 %).  




H NMR (400 MHz, CDCl3) 
δ 7.29 – 7.19 (7H, m, Ph), 6.82 (2H, d, J = 9.0 Hz, Ph), 4.10 (1H, t, J = 7.0 Hz, PhCH), 
3.74 (3H, s, OMe), 3.60 (1H, d, J = 13.5 Hz, SCH2Ph), 3.56 (1H, d, J = 13.0 Hz, 
SCH2Ph), 2.94 (1H, dd, J = 14.0 Hz, J’ = 7.0 Hz, CH2S), 2.82 (1H, dd, J = 14.0 Hz, J’ 
= 7.0 Hz, CH2S). 
13
C NMR (100 MHz, CDCl3): 159.7, 137.9, 130.2, 129.1, 128.6, 
128.5, 127.2, 114.2, 55.2, 54.8, 37.5, 36.6. HRMS calcd for C16H20NOS: 274.1265 and 
C16H19NOSNa: 296.1085, found 274.1260 (MH
+












Triethylamine (0.96 mL, 6.85 mmol, 2.5 equiv) was added to a solution of 65 (0.75 g, 
2.74 mmol, 1.0 equiv) in dry tetrahydrofuran (22 mL). The mixture was cooled to 0 
o
C 
and tert-butyl bromoacetate (1.02 mL, 6.85 mmol, 2.5 equiv) was added dropwise. The 
reaction mixture was then allowed to warm to room temperature and left for overnight. 
The resulting mixture was subsequently added to brine (50 mL), extracted with ethyl 
acetate (3 x 80 mL), dried over anhydrous MgSO4, filtered and concentrated in vacuo to 
give the crude product. Purification of the crude product over silica, eluting with petrol 
ether – diethyl ether (2 : 1), afforded 68 as a yellow oil (0.69 g, 65 %).  




H NMR (400 MHz, 
CDCl3) δ 7.33 – 7.22 (5H, m, Ph), 7.17 (2H, d, J = 8.5 Hz, Ph), 6.84 (2H, d, J = 8.5, 
Ph), 3.79 (3H, s, OMe), 3.75 (1H, d, J = 13.5 Hz, SCH2Ph), 3.70 (1H, d, J = 13.5 Hz, 
SCH2Ph), 3.66 (1H, dd, J = 9.0 Hz, J’ = 5.0 Hz, PhCH), 3.17 (1H, d, J = 17.5 Hz, CH2), 
2.98 (1H, d, J = 17.5 Hz, CH2), 2.66 (1H, dd, J = 13.5 Hz, J’= 5.0 Hz, CH2S), 2.58 (1H, 
dd, J = 14.0 Hz, J’ = 9.0 Hz, CH2S), 1.55 (1H, bs, NH), 1.45 (9H, s, tBu). 
13
C NMR 
(100 MHz, CDCl3): 171.7, 159.1, 138.3, 134.1, 129.0, 128.5, 127.0, 114.0, 81.0, 60.0, 
55.3, 49.3, 39.5, 36.0, 28.1. HRMS calcd for C22H30NO3S: 388.1946 and 
C22H29NO3SNa: 410.1765, found 388.1941 (MH
+










To a solution of 68 (0.41 g, 1.06 mmol, 1.0 equiv) in dichloromethane (60 mL) was 
added K2CO3 (0.73 g, 5.31 mmol, 5.0 equiv) and the mixture was allowed to stir for 10 
minutes. Fmoc-Cl (0.33 g, 1.27 mmol, 1.2 equiv) was subsequently added and the 
reaction mixture was left stirring overnight. The resulting mixture was quenched with 
water (30 mL) and extracted with dichloromethane (60 mL x 3). The combined extracts 
were dried over anhydrous MgSO4 and concentrated in vacuo to give the crude product 
that was purified by chromatography on silica, eluting with hexane – ethyl acetate (4 : 
1), to afford 69 as a yellow oil (0.39 g, 61 %). 




H NMR (400 MHz, 
CDCl3) δ 7.80 – 7.72 (4H, m, Ph), 7.64 – 7.59 (4H, m, Ph), 7.46 – 7.12 (18H, m, Ph), 
6.84 (4H, d, J = 8.50 Hz, Ph), 6.75 (4H, d, J = 8.5 Hz, Ph), 5.56 (1H, t, J = 8.0 Hz, CH), 
5.00 (1H, t, J = 8.0 Hz, CH), 4.80 (1H, dd, J = 11.0 Hz, J’ = 5.5 Hz, PhCH), 4.60 (1H, 
dd, J = 11.0 Hz, J’ = 5.5 Hz, SCH2), 4.49 (1H, dd, J = 10.5 Hz, J’ = 7.0 Hz, PhCH), 
4.40 (1H, dd, J = 10.5 Hz, J’ = 7.0 Hz, SCH2), 4.28 (1H, t, J = 5.5 Hz, SCH2), 4.23 (1H, 
t, J = 7.0 Hz, SCH2), 3.79 (3H, s, OCH3), 3.78 (3H, s, OCH3), 3.64 (1H, d, J = 18.0 Hz, 




2.97 (2H, d, J = 8.0 Hz, OCH2), 2.75 (2H, d, J = 8.0 Hz, OCH2), 1.30 (9H, bs, tBu). 
13
C 
NMR (100 MHz, CDCl3): 168.5, 159.3, 156.3, 144.0, 141.3, 138.2, 129.8, 129.3, 129.0, 
128.5, 127.7, 127.0, 125.2, 120.1, 113.9, 81.5, 67.9, 55.3, 47.4, 45.7, 36.5, 32.6, 27.9. 






To a solution of 69 (0.27 g, 0.44 mmol, 1.0 equiv) in dichloromethane (2 mL) was 
added TFA (2 mL) at 0 
o
C. The reaction was stirred for 30 minutes at 0 
o
C and the 
stirring was continued for an hour at room temperature. The mixture was evaporated in 
vacuo, redissolved in dichloromethane (5 mL), washed with saturated NaHCO3 (2 mL) 
and brine (2 mL), dried over anhydrous MgSO4, filtered and concentrated to give 63 as 
a yellow oil (0.18 g, 73 %). 





NMR (400 MHz, CDCl3) δ 7.73 (2H, d, J = 7.5 Hz, Ph), 7.57 (2H, d, J = 7.0 Hz, Ph), 
7.38 – 7.06 (9H, m, Ph), 6.83 (2H, d, J = 8.5 Hz, Ph), 6.68 (2H, dd, J = 11.0 Hz, J’= 8.5 
Hz, Ph), 4.38 (2H, d, J = 7.0 Hz, OCH2), 4.26 (1H, dd, J = 7.5 Hz, J’ = 5.0 Hz, PhCH), 
4.20 (1H, t, J = 7.0 Hz, CH), 3.80 (2H, s, SCH2Ph), 3.75 (3H, s, OCH3), 3.70 (1H, d, J 
= 17.0 Hz, NCH2), 3.63 (1H, d, J = 17.0 Hz, NCH2), 3.14 (1H, dd, J = 13.0 Hz, J’ = 5.0 
Hz, SCH2), 2.94 (1H, dd, J = 13.0 Hz, J’ = 8.0 Hz, SCH2). 
13




CDCl3): 170.0, 160.3, 158.4, 143.9, 141.4, 139.4, 136.7, 130.5, 129.9, 128.7, 127.8, 
127.2, 126.2, 125.2, 120.1, 113.9, 67.3, 61.9, 58.4, 55.3, 44.9, 34.5, 30.4. HRMS calcd 
for C33H31NO5SNa: 576.1821, found 576.1815 (MNa
+
). 






To a solution of potassium thioacetate (2.87 g, 25.1 mmol, 1.0 equiv) in tetrahydrofuran 
(65 mL) was added 2-bromoacetophenone (5 g, 25.1 mmol, 1.0 equiv) and the mixture 
was heated to 40 
o
C for 24 hours. The resulting mixture was then added to deionized 
water (50 mL), extracted with ethyl acetate (3 x 65 mL), the combined extracts dried 
over anhydrous Na2SO4, filtered and concentrated in vacuo to give 71 as a yellow oil 
(4.14 g, 85 %).  




H NMR (400 MHz, CDCl3) δ 8.00 
(2H, d, J = 7.0 Hz, Ph), 7.61 (1H, t, J = 7.5 Hz, Ph), 7.49 (2H, t, J = 7.5 Hz, Ph), 4.41 
(2H, s, CH2S), 2.41 (3H, s, CH3CO). 
13
C NMR (100 MHz, CDCl3): 192.4, 190.7, 132.7, 
130.4, 127.1, 43.6, 28.5. HRMS calcd for C10H11O2S: 195.0480 and C10H10O2SNa: 
217.0299, found 195.0474 (MH
+
) and 217.0294 (MNa
+
). 







A solution of 71 (4.0 g, 20.6 mmol, 1.0 equiv) in 1 M NaOH (20 mL) and MeOH (40 
mL) was stirred at room temperature for 24 hours. Deionized water (20 mL) was then 
added and the mixture was neutralized with 1 M HCl. The neutral mixture was 
extracted with ethyl acetate (60 mL x 3), the combined extracts dried over anhydrous 
Na2SO4, filtered and concentrated in vacuo to give the crude product that was purified 
over silica, eluting with petroleum ether – ethyl acetate (9 : 1), to afford 72 as yellow oil 
(1.72 g, 55 %).  




H NMR (400 MHz, CDCl3) δ 8.00 (2H, 
d, J = 7.0 Hz, Ph), 7.61 (1H, t, J = 7.5 Hz, Ph), 7.49 (2H, t, J = 7.5 Hz, Ph), 4.41 (2H, s, 
CH2S), 2.41 (3H, s, CH3CO). 
13
C NMR (100 MHz, CDCl3): 194.3, 135.4, 133.7, 128.8, 
45.4. HRMS calcd for C8H9OS: 153.0374 and C16H15O2S2: 303.0513, found 153.0367 
(MH
+
) and 303.0511 (dimer). 
Synthesis of (S)-(2-mercapto-1-phenylethyl)glycine (73) 
 
To a solution of 72 (0.15 g, 0.96 mmol, 1.0 equiv) in 1,2-dichloroethane (15 mL) was 
added glycine (72.3 mg, 0.96 mmol, 1.0 equiv). Sodium triacetoxyborohydride (0.29 g, 
1.35 mmol, 1.4 equiv) and acetic acid (0.06 g, 0.96 mmol, 1.0 equiv) were then added. 
The reaction mixture was stirred at room temperature under an atmosphere of nitrogen 
for 24 hours. The resulting mixture was quenched with NaHCO3 (15 mL), extracted 
with ether (3 x 30 mL), washed with brine (50 mL), dried over anhydrous MgSO4, 
filtered and concentrated in vacuo to give the crude product. Purification of the crude 
product over silica, eluting with hexane – ethyl acetate (1 : 4), afforded 73 as a yellow 





H NMR (400 MHz, CDCl3)  8.02 ppm (2H, d, J = 7.0 Hz, Ph), 7.62 ppm (1H, t, J = 
7.0 Hz, Ph), 7.50 ppm (2H, t, J = 7.5 Hz, Ph), 4.91 ppm (1H, bdt, J = 9.5 Hz, J’ = 3.0 
Hz, PhCH),4.17 ppm (1H, d, J = 14.0 Hz, CH2), 4.10 ppm (1H, d, J = 14.0 Hz, CH2),   
3.32 ppm (1H, b, NH), 3.11 ppm (1H, dd, J = 14.0 Hz, J’ = 3.0 Hz, CH2SH), 2.88 ppm 
(1H, dd, J = 14.0 Hz, J’ = 9.5 Hz, CH2SH). HRMS calcd for C9H13NS: 167.0769, found 
167.0126 [(M-CO2H)H
+
)   







To a solution of N-Fmoc-S-alanine (1.89 g, 6.07 mmol, 1.0 equiv) in dry 
dichloromethane (30 mL) was added thionyl chloride (7.22 g, 60.7 mmol, 10.0 equiv) 
and the mixture was heated at reflux for 2 hours under an atmosphere of nitrogen. The 
resulting mixture was evaporated in vacuo to give the crude product which was then 
purified over silica eluting with hexane – ethyl acetate (6 : 1) to afford 74 as a white 
solid (1.2 g, 60 %). mp. 88 – 90 
o
C.  




H NMR (400 MHz, DMSO d6) δ 7.90 
(2H, d, J = 7.5 Hz, Ph), 7.67 (2H, d, J = 7.5 Hz, Ph), 7.43 (2H, t, J = 7.5 Hz, Ph), 7.34 
(2H, t, J = 7.5 Hz, Ph), 4.29 (2H, d, J = 6.5 Hz, OCH2), 4.23 (1H, app q, J = 7.0 Hz, 






NMR (100 MHz, CDCl3): 175.3, 155.6, 144.0, 141.0, 127.8, 127.1, 125.1, 119.7, 66.5, 
65.2, 47.4, 18.4. HRMS calcd for C18H17ClNO3: 330.0897, found 330.0903 (MH
+
). 
Synthesis of (9H-fluoren-9-yl)methyl ((S)-1-oxo-1-((S)-3-
phenylthiomorpholino)propan-2-yl) carbamate (75) 
 
To a solution of 32 (92.8 mg, 0.48 mmol, 1.0 equiv) in dry dichloromethane (8 mL) was 
added Na2CO3 (255 mg, 2.40 mmol, 5.0 equiv). A solution of N-Fmoc-L-alanine acid 
chloride 74 (222 mg, 0.67 mmol, 1.4 equiv) in dry dichloromethane (2 mL) was then 
added dropwise under an atmosphere of nitrogen and the mixture was left overnight. 
The resulting mixture was filtered through a short pad of Celite
®
 and the filtrate 
concentrated in vacuo to give the crude product that was purified over silica, eluting 
with hexane – ethyl acetate (1 : 1), to afford 75 as a yellow oil (0.11 g, 46 %).  




H NMR (400 MHz, DMSO 
d6) δ 7.88 (2H, br d, J = 7.0 Hz, Ph), 7.72 – 7.65 (2H, m, Ph), 7.46 – 7.29 (9H, m, Ph), 
5.38 (1H, dd, J = 12.5 Hz, J’ = 7.0 Hz, PhCH), 4.85 (2H, d, J = 16.0 Hz, OCH2), 4.63 
(1H, d, J = 17.0 Hz, NCH2), 4.51 (1H, d, J = 17.0 Hz, NCH2), 4.27 – 4.20 (1H, br, 
CH3CH), 4.09 (1H, t, J = 16.5 Hz, CH), 3.67 – 3.59 (2H, br, SCH2), 1.19 (3H, d, J = 7.0 
Hz, CHCH3). 
13
C NMR (100 MHz, CDCl3): 195.5, 171.9, 164.6, 143.8, 141.3, 138.8, 
129.6, 129.2, 127.7, 127.1, 125.8, 125.2, 120.0, 67.1, 60.4, 54.7, 53.0, 47.1, 32.7, 19.0. 
HRMS calcd for C28H27N2O4S: 487.1692 and C28H26N2O4SNa: 509.1511, found 
487.1686 (MH
+












To a mixture of Na2CO3 (2.9 g, 27.5 mmol, 5.0 equiv) in deionized water – diethyl 
ether (1:1) (20 mL) was added S-alanine tert-butyl ester hydrochloride (1.0 g, 5.5 
mmol, 1.0 equiv) and the mixture was stirred for an hour under an atmosphere of 
nitrogen. The resulting mixture was then extracted with diethyl ether (3 x 20 mL), dried 
over anhydrous MgSO4, filtered and concentrated in vacuo to give 76 as a colourless oil 
(0.58 g, 72 %).  




H NMR (400 MHz, CDCl3) δ 3.42 (1H, q, J = 
7.0 Hz, CH), 1.57 (2H, br, NH2), 1.46 (9H, s, tBu), 1.29 (3H, d, J = 7.0 Hz, CH3CH). 
13
C NMR (100 MHz, CDCl3): 176.1, 80.8, 50.7, 28.0, 20.8. HRMS calcd for C7H16NO2: 






To a solution of 75 (0.12 mg, 0.25 mmol, 1.0 equiv) in dry dichloromethane (10 mL) 
was added a solution of L-alanine tert-butyl ester 76 (89.5 mg, 0.62 mmol, 2.5 equiv) in 




the reaction was left overnight. The resulting mixture was then filtered through a short 
pad of Celite
®
 and concentrated in vacuo to give the crude product. Purification of the 
crude product over silica eluting with diethyl ether – dichloromethane (6 : 1) afforded 
77 as yellow oil (43.3 mg, 28 %).  




H NMR (400 
MHz, CDCl3) δ 7.78 – 7.76 (2H, m, Ph), 7.61 – 7.60 (2H, br, Ph), 7.42 – 7.28 (9H, m, 
Ph), 5.79 (1H, dd, J = 10.0 Hz, J’ = 6.5 Hz, PhCH), 4.39 – 4.29 (1H, br m, CH3CH), 
4.27 – 4.17 (1H, br m, CH3CH), 3.93 (1H, d, J = 16.5 Hz, NCH2), 3.61 (1H, d, J = 16.5 
Hz, NCH2), 3.12 – 3.00 (2H, m, CH2SH), 1.44 (3H, d, J = 6.5 Hz, CHCH3), 1.39 (3H, 
d, J = 6.0 Hz, CHCH3), 1.25 (9H, bs, tBu). 
13
C NMR (100 MHz, CDCl3): 177.6, 172.3, 
171.4, 153.2, 143.8, 141.2, 135.9, 129.0, 128.7, 127.8, 127.2, 125.2, 120.0, 82.0, 68.1, 
67.2, 49.8, 48.7, 47.2, 45.2, 29.7, 27.9, 26.2, 24.4. HRMS calcd for C35H42N3O6S: 
632.2794 and C35H41N3O6SNa: 654.2614, found 632.2789 (MH
+
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